<?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName art560.dtd?>
<?SourceDTD.Version 5.6.0?>
<?ConverterInfo.XSLTName elsevier2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<?origin publisher?>
<?FILEmeta_XHGG100143 xml ?>
<?FILEmain xml ?>
<?FILEmain pdf ?>
<?FILEgr1 jpg ?>
<?FILEgr2 jpg ?>
<?FILEgr3 jpg ?>
<?FILEgr4 jpg ?>
<?FILEmmc1 pdf ?>
<?FILEmmc2 pdf ?>
<?FILEsi1 gif ?>
<?FILEsi2 gif ?>
<?FILEsi3 gif ?>
<?FILEsi4 gif ?>
<?FILEsi5 gif ?>
<?FILEsi6 gif ?>
<?FILEsi7 gif ?>
<?FILEsi8 gif ?>
<?FILEsi9 gif ?>
<?FILEsi10 gif ?>
<?FILEsi11 gif ?>
<?FILEsi12 gif ?>
<?FILEsi13 gif ?>
<?FILEsi14 gif ?>
<?FILEsi15 gif ?>
<?FILEsi16 gif ?>
<?FILEsi17 gif ?>
<?FILEsi18 gif ?>
<?FILEsi19 gif ?>
<?FILEsi20 gif ?>
<?FILEsi21 gif ?>
<?FILEsi22 gif ?>
<?FILEsi23 gif ?>
<?FILEsi24 gif ?>
<?FILEsi25 gif ?>
<?FILEsi26 gif ?>
<?FILEsi27 gif ?>
<?FILEsi28 gif ?>
<?FILEsi29 gif ?>
<?FILEsi30 gif ?>
<?FILEsi31 gif ?>
<?FILEsi32 gif ?>
<?FILEsi33 gif ?>
<?FILEsi34 gif ?>
<?FILEsi35 gif ?>
<?FILEsi36 gif ?>
<?FILEsi37 gif ?>
<?FILEsi38 gif ?>
<?FILEsi39 gif ?>
<?FILEsi40 gif ?>
<?FILEsi41 gif ?>
<?FILEsi42 gif ?>
<?FILEsi43 gif ?>
<?FILEsi44 gif ?>
<?FILEsi45 gif ?>
<?FILEsi46 gif ?>
<?FILEsi47 gif ?>
<?FILEsi48 gif ?>
<?FILEsi49 gif ?>
<?FILEsi50 gif ?>
<?FILEsi51 gif ?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">HGG Adv</journal-id>
    <journal-id journal-id-type="iso-abbrev">HGG Adv</journal-id>
    <journal-title-group>
      <journal-title>Human Genetics and Genomics Advances</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2666-2477</issn>
    <publisher>
      <publisher-name>Elsevier</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9530673</article-id>
    <article-id pub-id-type="pii">S2666-2477(22)00060-4</article-id>
    <article-id pub-id-type="doi">10.1016/j.xhgg.2022.100143</article-id>
    <article-id pub-id-type="publisher-id">100143</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>A scalable Bayesian functional GWAS method accounting for multivariate quantitative functional annotations with applications for studying Alzheimer disease</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" id="au1">
        <name>
          <surname>Chen</surname>
          <given-names>Junyu</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">1</xref>
        <xref rid="aff2" ref-type="aff">2</xref>
      </contrib>
      <contrib contrib-type="author" id="au2">
        <name>
          <surname>Wang</surname>
          <given-names>Lei</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="aff3" ref-type="aff">3</xref>
      </contrib>
      <contrib contrib-type="author" id="au3">
        <name>
          <surname>De Jager</surname>
          <given-names>Philip L.</given-names>
        </name>
        <xref rid="aff4" ref-type="aff">4</xref>
      </contrib>
      <contrib contrib-type="author" id="au4">
        <name>
          <surname>Bennett</surname>
          <given-names>David A.</given-names>
        </name>
        <xref rid="aff5" ref-type="aff">5</xref>
      </contrib>
      <contrib contrib-type="author" id="au5">
        <name>
          <surname>Buchman</surname>
          <given-names>Aron S.</given-names>
        </name>
        <xref rid="aff5" ref-type="aff">5</xref>
      </contrib>
      <contrib contrib-type="author" id="au6">
        <name>
          <surname>Yang</surname>
          <given-names>Jingjing</given-names>
        </name>
        <email>jingjing.yang@emory.edu</email>
        <xref rid="aff2" ref-type="aff">2</xref>
        <xref rid="fn1" ref-type="fn">6</xref>
        <xref rid="cor1" ref-type="corresp">∗</xref>
      </contrib>
      <aff id="aff1"><label>1</label>Department of Epidemiology, Emory University School of Public Health, Atlanta, GA 30322, USA</aff>
      <aff id="aff2"><label>2</label>Center for Computational and Quantitative Genetics, Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA</aff>
      <aff id="aff3"><label>3</label>Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA</aff>
      <aff id="aff4"><label>4</label>Center for Translational and Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY 10032, USA</aff>
      <aff id="aff5"><label>5</label>Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago, IL 60612, USA</aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>∗</label>Corresponding author <email>jingjing.yang@emory.edu</email></corresp>
      <fn id="fn1">
        <label>6</label>
        <p id="ntpara0010">Lead contact</p>
      </fn>
    </author-notes>
    <pub-date pub-type="pmc-release">
      <day>17</day>
      <month>9</month>
      <year>2022</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
    <pub-date pub-type="collection">
      <day>13</day>
      <month>10</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub">
      <day>17</day>
      <month>9</month>
      <year>2022</year>
    </pub-date>
    <volume>3</volume>
    <issue>4</issue>
    <elocation-id>100143</elocation-id>
    <history>
      <date date-type="received">
        <day>28</day>
        <month>1</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>14</day>
        <month>9</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 The Author(s)</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
      </license>
    </permissions>
    <abstract id="abs0010">
      <title>Summary</title>
      <p>Existing methods for integrating functional annotations in genome-wide association studies (GWASs) to fine-map and prioritize potential causal variants are limited to using non-overlapped categorical annotations or limited by the computation burden of modeling genome-wide variants. To overcome these limitations, we propose a scalable Bayesian functional GWAS method to account for multivariate quantitative functional annotations (BFGWAS_QUANT), accompanied by a scalable computation algorithm enabling joint modeling of genome-wide variants. Simulation studies validated the performance of BFGWAS_QUANT for accurately quantifying annotation enrichment and improving GWAS power. Applying BFGWAS_QUANT to study five Alzheimer disease (AD)-related phenotypes using individual-level GWAS data (n = ∼1,000), we found that histone modification annotations have higher enrichment than expression quantitative trait locus (eQTL) annotations for all considered phenotypes, with the highest enrichment in H3K27me3 (polycomb regression). We also found that <italic>cis</italic>-eQTLs in microglia had higher enrichment than eQTLs of bulk brain frontal cortex tissue for all considered phenotypes. A similar enrichment pattern was also identified using the International Genomics of Alzheimer’s Project (IGAP) summary-level GWAS data of AD (n = ∼54,000). The strongest known <italic>APOE E4</italic> risk allele was identified for all five phenotypes, and the <italic>APOE</italic> locus was validated using the IGAP data. BFGWAS_QUANT fine-mapped 32 significant variants from 1,073 genome-wide significant variants in the IGAP data. We also demonstrated that the polygenic risk scores (PRSs) using effect size estimates by BFGWAS_QUANT had a similar prediction accuracy as other methods assuming a sparse causal model. Overall, BFGWAS_QUANT is a useful GWAS tool for quantifying annotation enrichment and prioritizing potential causal variants.</p>
    </abstract>
    <abstract abstract-type="teaser" id="abs0015">
      <p>Chen et al. propose a scalable Bayesian functional GWAS method to account for multivariate quantitative functional annotations (BFGWAS_QUANT) for studying complex traits that can quantify annotation enrichment and model LD to generate fine-mapped and prioritized GWAS results. BFGWAS_QUANT can be applied to individual-level and summary-level GWAS data of the same ancestry.</p>
    </abstract>
    <kwd-group id="kwrds0010">
      <title>Keywords</title>
      <kwd>Bayesian hierarchical variable selection regression</kwd>
      <kwd>quantitative functional annotation</kwd>
      <kwd>genome-wide association study</kwd>
      <kwd>molecular quantitative trait loci</kwd>
      <kwd>polygenic risk score</kwd>
      <kwd>Alzheimer disease</kwd>
      <kwd>fine-mapping</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p id="p0010">Although thousands of significant associations have been identified by single-variant genome-wide association studies (GWASs) for complex traits and diseases, the majority of GWAS signals reside in the noncoding genome regions and have unknown biological meaning.<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref> Existing GWAS results based on single-variant tests are still difficult to interpret with respect to the underlying biological mechanisms.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> Promising advancements in sequencing technology have made plenteous multi-omics data available that provide functional annotations of genetic variants available to the scientific community: Combined Annotation-Dependent Depletion (CADD) score;<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> the Roadmap Epigenomics Mapping Consortium,<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> providing DNA methylation, histone modification, and chromatin accessibility information for various human tissues; the Encyclopedia of DNA Elements (ENCODE),<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> providing functional information of human and mouse genomes; and the Genotype-Tissue Expression (GTEx) project,<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> providing expression quantitative trait locus (eQTL) information of 54 human tissues. In particular, molecular QTLs mapped from profiles of molecular phenotypes (e.g., gene expression from GTEx,<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> chromatin marks from Roadmap,<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="bib10" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> and protein abundances<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref>) and corresponding genomes (genotype data) have been shown to be enriched with GWAS signals and help interpretate the underlying biology for studying complex traits and diseases.<xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref> These molecular QTL have been leveraged especially to prioritize GWAS associations of complex traits and diseases.<xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref>, <xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib20" ref-type="bibr">20</xref></p>
    <p id="p0015">An intuitive but widely used <italic>ad hoc</italic> approach is to fine-map and prioritize potential causal GWAS signals that are also molecular QTLs<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> or located in a region with histone modifications. Recently, advanced statistical methods have been proposed to integrate non-overlapped categorical functional annotation (assigning one function label per variant) with GWAS data to fine-map GWAS results.<xref rid="bib22" ref-type="bibr">22</xref>, <xref rid="bib23" ref-type="bibr">23</xref>, <xref rid="bib24" ref-type="bibr">24</xref>, <xref rid="bib25" ref-type="bibr">25</xref>, <xref rid="bib26" ref-type="bibr">26</xref> PAINTOR has been proposed to integrate multivariate quantitative functional annotations with GWAS summary statistics to fine-map GWAS loci with thousands of variants<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="bib28" ref-type="bibr"><sup>28</sup></xref>; FunSPU<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> and STAAR<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> have been proposed to incorporate multiple biological annotations for rare variant association tests. These existing methods have shown the feasibility and promising results of integrating multivariate quantitative functional annotations with GWAS data to fine-map GWAS results and prioritize potential causal variants. However, these methods were not developed for joint modeling millions of genome-wide variants with multivariate quantitative annotations, which would lead to less accurate quantification of annotation enrichment and reduced power of fine-mapping.</p>
    <p id="p0020">Here, we propose a scalable Bayesian functional GWAS method for integrating multivariate quantitative functional annotations with GWAS data by a Bayesian hierarchical variable selection regression model, referred to as BFGWAS_QUANT. BFGWAS_QUANT assumes a hierarchical logistic prior for the causal probabilities of genetic variants in the standard Bayesian variable selection regression (BVSR)-based GWAS method<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> to jointly model millions of genome-wide genetic variants. BFGWAS_QUANT adapts the scalable expectation maximization Markov chain Monte Carlo (EM-MCMC) algorithm developed by the previous Bayesian functional GWAS (BFGWAS) method, which only models non-overlapped categorical annotations (referred to as BFGWAS_CAT in this paper).<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> BFGWAS_QUANT further improves the computation efficiency by pre-calculating the linkage disequilibrium (LD) correlation matrix and single variant test <italic>Z</italic> score statistics that are used in the MCMC algorithm or using reference LD correlation matrix and summary-level GWAS data. Bayesian causal posterior probability (CPP) and genetic effect size estimates will be generated by BFGWAS_QUANT, along with enrichment quantification of considered multivariate quantitative functional annotations. Bayesian estimates of genetic effect sizes can be used to derive polygenic risk scores (PRSs) that account for functional annotations.</p>
    <p id="p0025">By simulation studies, we showed that our Bayesian estimates of functional enrichment converged and GWAS power was improved over the standard BVSR method without accounting for functional annotations.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> We then applied BFGWAS_QUANT to real GWAS data for studying Alzheimer disease (AD) related phenotypes,<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> accounting for multivariate quantitative annotations with respect to Roadmap histone modifications<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> of brain mid-frontal gyrus, eQTLs of brain frontal cortex tissue<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> and eQTLs of microglia cell type.<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref><sup>,</sup><xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> We showed that BFGWAS_QUANT identified interesting enrichment patterns and generated fine-mapped GWAS results using individual-level and summary-level GWAS data. We also showed that PRSs derived from BFGWAS_QUANT effect size estimates led to similar accurate AD risk prediction as other PRS methods assuming a sparse causal model.</p>
    <p id="p0030">Under <xref rid="sec2" ref-type="sec">Material and methods</xref>, we provide an overview of the BFGWAS_QUANT method, Roadmap histone modification and eQTL-based quantitative functional annotations, simulation study design, and application studies of AD. Under <xref rid="sec3" ref-type="sec">Results</xref>, we describe the results of simulation and application studies. We then end with a Discussion of the advantages and limitations of BFGWAS_QUANT.</p>
  </sec>
  <sec id="sec2">
    <title>Material and methods</title>
    <sec id="sec2.1">
      <title>Hierarchical BVSR model</title>
      <p id="p0035">BFGWAS_QUANT assumes a hierarchical BVSR<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> model for genome-wide variants,<disp-formula id="fd1"><label>(Equation 1)</label><mml:math id="M1" altimg="si1.gif"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">n</mml:mi><mml:mo linebreak="badbreak">×</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:msub><mml:mi mathvariant="bold-italic">X</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">n</mml:mi><mml:mo linebreak="badbreak">×</mml:mo><mml:mi mathvariant="bold-italic">p</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="bold-italic">β</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">p</mml:mi><mml:mo linebreak="badbreak">×</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo linebreak="badbreak">+</mml:mo><mml:msub><mml:mi mathvariant="normal">ϵ</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">n</mml:mi><mml:mo linebreak="badbreak">×</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>;</mml:mo><mml:msub><mml:mi mathvariant="normal">ϵ</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">n</mml:mi><mml:mo linebreak="badbreak">×</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>∼</mml:mo><mml:mtext>N</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.5em"/><mml:mi mathvariant="bold-italic">I</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>n</mml:mi></mml:mfrac><mml:msubsup><mml:mi>τ</mml:mi><mml:mi>β</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">−</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi>δ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="1em"/><mml:mi>i</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>;</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="M2" altimg="si2.gif"><mml:mrow><mml:msub><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">n</mml:mi><mml:mo>×</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is a vector of standardized phenotype with <italic>n</italic> subjects, <inline-formula><mml:math id="M3" altimg="si3.gif"><mml:mrow><mml:msub><mml:mi mathvariant="bold-italic">X</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">n</mml:mi><mml:mo>×</mml:mo><mml:mi mathvariant="bold-italic">p</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is the standardized genotype matrix with <italic>p</italic> genome-wide genetic variants, and <inline-formula><mml:math id="M4" altimg="si4.gif"><mml:mrow><mml:msub><mml:mi mathvariant="bold-italic">β</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">p</mml:mi><mml:mo>×</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> is the vector of the genetic effect sizes. Spike-and-slab variable selection prior is assumed per effect size <inline-formula><mml:math id="M5" altimg="si5.gif"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>. That is, <inline-formula><mml:math id="M6" altimg="si5.gif"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> has probability <inline-formula><mml:math id="M7" altimg="si6.gif"><mml:mrow><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> to be non-zero and follows a normal distribution centered at zero and probability <inline-formula><mml:math id="M8" altimg="si7.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">−</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> to be zero with a point-mass density function at 0, where <inline-formula><mml:math id="M9" altimg="si6.gif"><mml:mrow><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> denotes the “casual” probability of the <italic>i</italic> th variant.</p>
      <p id="p0040">We assume a hierarchical logistic model for the causal probabilities of genetic variants to account for multivariate quantitative functional annotations,<disp-formula id="fd2"><label>(Equation 2)</label><mml:math id="M10" altimg="si8.gif"><mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:msubsup><mml:mi mathvariant="bold-italic">A</mml:mi><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mi mathvariant="bold-italic">α</mml:mi><mml:mo>,</mml:mo><mml:mspace width="0.5em"/><mml:mi>i</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:math></disp-formula>where <inline-formula><mml:math id="M11" altimg="si6.gif"><mml:mrow><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> denotes the casual probability of the <italic>i</italic> th variant as in <xref rid="fd1" ref-type="disp-formula">Equation 1</xref>, <inline-formula><mml:math id="M12" altimg="si9.gif"><mml:mrow><mml:msub><mml:mi mathvariant="bold-italic">A</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.5em"/><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>J</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math></inline-formula> denotes the augmented annotation vector for the <italic>i</italic> th variant with an intercept term as the first element, and coefficient vector <inline-formula><mml:math id="M13" altimg="si10.gif"><mml:mrow><mml:mi mathvariant="bold-italic">α</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.5em"/><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mi>J</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math></inline-formula> denotes the intercept term <inline-formula><mml:math id="M14" altimg="si11.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> and enrichment quantification with respect to functional annotation <inline-formula><mml:math id="M15" altimg="si12.gif"><mml:mrow><mml:mi>j</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow></mml:math></inline-formula>.</p>
      <p id="p0045">Further, we assume a fixed value in the domain of (0, 1] for <inline-formula><mml:math id="M16" altimg="si13.gif"><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mi>β</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math></inline-formula> a fixed value for <inline-formula><mml:math id="M17" altimg="si11.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> in the domain of (−13.8, −9), and a standard normal prior for enrichment parameters <inline-formula><mml:math id="M18" altimg="si14.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>0,1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>;</mml:mo><mml:mi>j</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0,1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mi>J</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. In particular, <inline-formula><mml:math id="M19" altimg="si15.gif"><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mi>β</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula> would assume that the prior variance of effect sizes is the same as the marginal effect size estimates in a single-variant regression model, and smaller <inline-formula><mml:math id="M20" altimg="si16.gif"><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mi>β</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula> values would inflate the magnitude of Bayesian effect size estimates. The lower bound value of <inline-formula><mml:math id="M21" altimg="si17.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:mn>13.8</mml:mn></mml:mrow></mml:math></inline-formula> would assume that the prior causal probability is 10<sup>−6</sup> when <inline-formula><mml:math id="M22" altimg="si18.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow></mml:math></inline-formula> (see <xref rid="mmc1" ref-type="supplementary-material">supplemental information</xref> for model details).</p>
    </sec>
    <sec id="sec2.2">
      <title>Adapted EM-MCMC algorithm</title>
      <p id="p0050">To overcome the heavy computational burden and poor mixing rate of posterior samplings by the standard MCMC algorithm,<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> we adapt the scalable EM-MCMC algorithm developed for the original BFGWAS method.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> Specifically, we first segment genome-wide variants into approximately independent genome blocks with about 5,000–10,000 variants based on LD structure.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> Second, conditioning on given hyperparameters <inline-formula><mml:math id="M23" altimg="si19.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, we conduct a standard MCMC algorithm within each genome block to obtain Bayesian posterior estimates for genetic effect size (<inline-formula><mml:math id="M24" altimg="si5.gif"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) and causal probability (<inline-formula><mml:math id="M25" altimg="si6.gif"><mml:mrow><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) per variant (expectation (E) step). Third, conditioning on the Bayesian estimates of <inline-formula><mml:math id="M26" altimg="si20.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, we update the values of hyperparameters <inline-formula><mml:math id="M27" altimg="si21.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> by maximizing their conditional posterior likelihood (maximization [M] step). The computational optimization algorithm Broyden-Fletcher-Goldfarb-Shanno (BFGS)<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> is used to obtain the maximum <italic>a posteriori</italic> (MAP) estimates for <inline-formula><mml:math id="M28" altimg="si22.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow></mml:math></inline-formula>. The EM steps will be iterated (∼5 iterations) until the estimates of hyperparameters converge.</p>
      <p id="p0055">The Bayesian estimate for the causal probability (<inline-formula><mml:math id="M29" altimg="si6.gif"><mml:mrow><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) per variant is referred to as CPP, and the Bayesian estimates for annotation coefficients <inline-formula><mml:math id="M30" altimg="si23.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>J</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> are referred to as quantified enrichment of multivariate functional annotations. SNPs with CPP greater than 0.1068 will be considered significantly associated with the phenotype of interest, where the significance threshold has been shown to be equivalent to p &lt; 5 × 10<sup>−8</sup> in a previously published BFGWAS_CAT paper.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> Because a multivariate regression model is fitted per genome block, the LD among all variants per genome block is accounted for during the Bayesian inference of CPP and effect size <italic>β</italic>. The GWAS results obtained by BFGWAS_QUANT will be fine-mapped, and variants with enriched annotations will be prioritized.</p>
      <p id="p0060">In particular, implementing the MCMC algorithm per genome block can greatly reduce the search space (from genome-wide to a genome block) and facilitate parallel computing (one core per genome block), leading to an efficient convergence rate and improved mixing rate. Computation efficiency is further improved by implementing the MCMC algorithm using a pre-calculated LD correlation matrix per genome block and single-variant test <italic>Z</italic> score statistics or a reference LD correlation matrix and GWAS <italic>Z</italic> score statistics, which will save up to 90% computation time compared with using individual-level GWAS data.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> With 32 computation cores in one node, BFGWAS_QUANT can complete analyzing approximately 10 million SNPs in approximately 4 h for 5 EM iterations.</p>
    </sec>
    <sec id="sec2.3">
      <title>eQTL-based functional annotations</title>
      <p id="p0065">In this paper, we considered 5 real eQTL-based quantitative functional annotations. Three of these annotations (Allcis-eQTL, 95%CredibleSet, and MaxCPP) were constructed based on standard <italic>cis</italic>-eQTL data of brain frontal cortex tissue from GTEx data<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="bib34" ref-type="bibr"><sup>34</sup></xref>: (1) binary annotation Allcis-eQTL was constructed by taking all SNPs that were identified as a significant <italic>cis</italic>-eQTL (false discovery rate [FDR] &lt; 5%; 1 Mb from the transcription start site [TSS]) for at least one expression quantitative trait (one gene) as 1 and otherwise as 0. (2) For each gene expression trait that has at least one significant (FDR &lt; 5%) <italic>cis</italic>-eQTL, CAVIAR<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> was used to calculate the CPP (<italic>cis</italic>-CPP) of each <italic>cis</italic>-SNP and identify a 95% credible set. SNPs that do not belong to any 95% credible set were taken as 0 or otherwise 1 for the annotation of 95%CredibleSet. (3) Maximum <italic>cis</italic>-CPPs per SNP across all genes were taken as quantitative values of MaxCPP. We also took the maximum Bayesian genome-wide CPP of being <italic>cis</italic>- or <italic>trans</italic>-eQTL across all genes in brain frontal cortex tissue from the Religious Orders Study and Rush Memory and Aging Project (ROS/MAP)<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> as the fourth annotation BGW_MaxCPP, where <italic>cis</italic>- and <italic>trans</italic>-CPPs were estimated by Bayesian genome-wide transcriptome-wide association study (BGW-TWAS) method.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> Last, we derived a fifth Microglia-eQTL annotation from two datasets of recent microglia cell-type specific eQTL summary statistics,<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref><sup>,</sup><xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> where 1 indicates being identified as a <italic>cis</italic>-eQTL to any gene in either microglia dataset or otherwise 0.</p>
    </sec>
    <sec id="sec2.4">
      <title>Histone modification-based functional annotation</title>
      <p id="p0070">We constructed 5 histone modification-based functional annotations using the epigenomics data of core histone modifications in the brain mid-frontal gyrus region from the Roadmap Epigenomics database:<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> H3K4me1 (primed enhancers), H3K4me3 (promoters), H3K36me3 (gene bodies), H3K27me3 (polycomb regression), and H3K9me3 (heterochromatin). For each histone modification, peak regions from replicates of the same sample were first merged and then overlapped with peak regions of other samples by Bedtools (v.2.27.0).<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> If a genetic variant resides in the overlapped peak regions of a histone modification, then 1 would be assigned to the function annotation of such a modification for this variant, or 0 would be assigned otherwise.</p>
    </sec>
    <sec id="sec2.5">
      <title>Simulation study design</title>
      <p id="p0075">We conducted simulation studies to validate the performance of BFGWAS_QUANT. Continuous phenotypes were simulated using the real whole-genome sequence (WGS) data of chromosomes 19 (122,745 SNPs with minor allele frequency [MAF] &gt; 0.01) for 1,893 samples from the ROS/MAP cohort<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> and Mount Sinai Brain Bank (MSBB) study.<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref> Phenotypes were simulated based on the multivariate linear additive model (<xref rid="fd1" ref-type="disp-formula">Equation 1</xref>) with true genetic effect sizes <inline-formula><mml:math id="M31" altimg="si4.gif"><mml:mrow><mml:msub><mml:mi mathvariant="bold-italic">β</mml:mi><mml:mrow><mml:mi mathvariant="bold-italic">p</mml:mi><mml:mo>×</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> generated based on the hierarchical logistic model with multivariate quantitative functional annotations (<xref rid="fd2" ref-type="disp-formula">Equation 2</xref>). Scenarios with various numbers of true causals and heritability were considered.</p>
      <p id="p0080">Besides the real <italic>cis</italic>-eQTL-based functional annotations of Allcis-QTL, 95%CredibleSet, and MaxCPP, we also considered a fourth artificial annotation randomly generated from <italic>N</italic>(0, 1) as a negative control. With chosen annotation enrichment parameters (<inline-formula><mml:math id="M32" altimg="si24.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:mn>10.5</mml:mn><mml:mo>,</mml:mo><mml:mo linebreak="badbreak">−</mml:mo><mml:mn>9.5</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>4</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1.5</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.5</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula>), we first calculated casual probabilities <inline-formula><mml:math id="M33" altimg="si25.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> for all considered 122,745 SNPs by <xref rid="fd2" ref-type="disp-formula">Equation 2</xref>, where <inline-formula><mml:math id="M34" altimg="si11.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> was chosen to ensure the total number of true causal SNPs fall in (5, 10) with <inline-formula><mml:math id="M35" altimg="si26.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:mn>10.5</mml:mn></mml:mrow></mml:math></inline-formula> or (15, 30) with <inline-formula><mml:math id="M36" altimg="si27.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:mn>9.5</mml:mn></mml:mrow></mml:math></inline-formula>. Second, a vector of binary indicator <inline-formula><mml:math id="M37" altimg="si28.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>γ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> of true causal SNPs was generated from the corresponding Bernoulli distribution with probability (<inline-formula><mml:math id="M38" altimg="si6.gif"><mml:mrow><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>) for <inline-formula><mml:math id="M39" altimg="si29.gif"><mml:mrow><mml:mi>i</mml:mi><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:math></inline-formula>. Third, genetic effect sizes were taken as 0 for SNPs with <inline-formula><mml:math id="M40" altimg="si30.gif"><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></inline-formula> or generated from a normal distribution for SNPs with <inline-formula><mml:math id="M41" altimg="si31.gif"><mml:mrow><mml:msub><mml:mi>γ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math></inline-formula>. Finally, phenotypes were generated from <xref rid="fd1" ref-type="disp-formula">Equation 1</xref> with simulated genetic effect sizes and random errors <inline-formula><mml:math id="M42" altimg="si32.gif"><mml:mrow><mml:mi mathvariant="normal">ϵ</mml:mi><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="badbreak">−</mml:mo><mml:msup><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi mathvariant="bold-italic">I</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> to ensure that a target total heritability <inline-formula><mml:math id="M43" altimg="si33.gif"><mml:mrow><mml:msup><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0.25</mml:mn><mml:mo>,</mml:mo><mml:mn>0.5</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> was equally explained by all true causal SNPs. Four scenarios were considered, including one with relatively sparse true causals in the range of (5, 10) and one with the number of true causals in the range of (15, 30) with respect to two different heritability values (0.25, 0.5).</p>
      <p id="p0085">We considered a null enrichment scenario where none of the annotations were enriched. In this scenario, we randomly selected 10 true causal SNPs and assigned them genetic effect sizes generated from a normal distribution. We simulated the phenotype as described above with a targeted <italic>h</italic><sup><italic>2</italic></sup> = 0.5.</p>
      <p id="p0090">We repeated 100 simulations per scenario to evaluate our Bayesian estimates for annotation enrichment, total heritability, and true causal SNPs with respect to sensitivity (power) and positive predictive values (PPVs).<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> Sensitivity (power) is defined as the proportion of true positive findings among all true casual variants, and PPV is defined as the proportion of true positive findings among all identified significant associations. We took simulated true casual SNPs and those having <inline-formula><mml:math id="M44" altimg="si34.gif"><mml:mrow><mml:msup><mml:mi>R</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo linebreak="goodbreak" linebreakstyle="after">&gt;</mml:mo><mml:mn>0.3</mml:mn></mml:mrow></mml:math></inline-formula> with true casual SNPs with <inline-formula><mml:math id="M45" altimg="si35.gif"><mml:mrow><mml:mover accent="true"><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="true">ˆ</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> &gt;0.1 as true positive findings, following the significance rule used by the BFGWAS_CAT method.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> The sensitivity and PPV are given by<disp-formula id="ufd1"><mml:math id="M46" altimg="si36.gif"><mml:mrow><mml:mi>S</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>y</mml:mi><mml:mspace width="0.25em"/><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:mo>#</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>P</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>F</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mo>#</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>C</mml:mi><mml:mi>a</mml:mi><mml:mi>u</mml:mi><mml:mi>s</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mspace width="0.25em"/><mml:mi>S</mml:mi><mml:mi>N</mml:mi><mml:mi>P</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:mfrac><mml:mo>;</mml:mo></mml:mrow></mml:math></disp-formula><disp-formula id="ufd2"><mml:math id="M47" altimg="si37.gif"><mml:mrow><mml:mi>P</mml:mi><mml:mi>P</mml:mi><mml:mi>V</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:mo>#</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>P</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>F</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mo>#</mml:mo><mml:mspace width="0.25em"/><mml:mi>P</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mspace width="0.25em"/><mml:mi>F</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>g</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p>
      <p id="p0095">We compared this with the standard BVSR method,<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> which does not account for functional annotations. We estimated the total heritability by the squared correlation between the simulated phenotypes and the PRSs based on Bayesian estimates of genetic effect sizes (<inline-formula><mml:math id="M48" altimg="si38.gif"><mml:mrow><mml:mover accent="true"><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="true">ˆ</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>) of SNPs with <inline-formula><mml:math id="M49" altimg="si35.gif"><mml:mrow><mml:mover accent="true"><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="true">ˆ</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula> &gt; 0.01,<disp-formula id="fd3"><label>(Equation 3)</label><mml:math id="M50" altimg="si39.gif"><mml:mrow><mml:mi>P</mml:mi><mml:mi>R</mml:mi><mml:mi>S</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>p</mml:mi></mml:msubsup><mml:mrow><mml:msub><mml:mi>I</mml:mi><mml:mrow><mml:mover accent="true"><mml:msub><mml:mi>π</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="true">ˆ</mml:mo></mml:mover><mml:mo linebreak="badbreak">&gt;</mml:mo><mml:mn>0.01</mml:mn></mml:mrow></mml:msub><mml:mover accent="true"><mml:msub><mml:mi>β</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="true">ˆ</mml:mo></mml:mover><mml:msub><mml:mi>X</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mspace width="0.25em"/><mml:mo>.</mml:mo></mml:mrow></mml:math></disp-formula></p>
    </sec>
    <sec id="sec2.6">
      <title>Applications to ROS/MAP individual-level GWAS data</title>
      <p id="p0100">ROS/MAP are two prospective longitudinal community-based cohort studies that recruit older adults without known dementia at baseline and follow up with participants annually until the time of death.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib40" ref-type="bibr"><sup>40</sup></xref><sup>,</sup><xref rid="bib43" ref-type="bibr"><sup>43</sup></xref> Participants agree to annual clinical evaluation and brain autopsy at the time of death, signing an informed consent form and Anatomic Gift Act. All participants in this study also sign a repository consent to allow their data to be re-purposed. WGS data were profiled for 1,200 samples by using the KAPA Hyper Library Preparation Kit and Illumina HiSeq X sequencer.</p>
      <p id="p0105">We applied BFGWAS_QUANT to account for five eQTL-based and five histone modification-based quantitative annotations as described above to study five AD-related phenotypes,<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="bib32" ref-type="bibr">32</xref>, <xref rid="bib33" ref-type="bibr">33</xref>, <xref rid="bib34" ref-type="bibr">34</xref> including the binary clinical diagnosis of late-onset Alzheimer dementia (n = 1,087), three quantified postmortem pathology indices of AD (i.e., PHFtau tangle density with n = 1,105, β-amyloid load with n = 1,113, and a global measurement of AD pathology burden with n = 1,123), and a quantitative measurement of cognition decline rate with n = 1,049.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> The cognition decline rate was constructed as the random slope per sample from a linear mixed model of annual longitudinal measurements of cognition function. Details about ROS/MAP and phenotypic traits measured can be found in a previously published paper.<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> We also adjusted for the covariates of age, sex, smoking status, study index (ROS or MAP), and first 3 genotype principal components by regressing these covariates out from the phenotypes and taking the corresponding regression residuals as the outcome in the BFGWAS_QUANT method.</p>
    </sec>
    <sec id="sec2.7">
      <title>Application to IGAP summary-level GWAS data</title>
      <p id="p0110">We applied BFGWAS_QUANT to the stage 1 summary-level GWAS data of the International Genomics of Alzheimer’s Project (IGAP),<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> along with the above 10 eQTL- and histone modification-based functional annotations and reference LD generated from ROS/MAP. The stage 1 IGAP summary-level GWAS data were generated by meta-analyses consisting of 17,008 individuals with AD and 37,154 control individuals of European ancestry (n = ∼54,000).</p>
    </sec>
    <sec id="sec2.8">
      <title>AD risk prediction by PRS</title>
      <p id="p0115">To show the usefulness of PRSs for risk prediction, we evaluated two sets of PRSs that were, respectively, derived from BFGWAS_QUANT and BVSR summary statistics using ROS/MAP GWAS data. We used the independent test samples from Mayo Clinic Alzheimer’s Disease Genetics Studies (MCADGS).<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="bib47" ref-type="bibr"><sup>47</sup></xref> MCADGS contain 2,099 European-descent samples (844 individuals with AD and 1,255 control individuals) with microarray genotype data profiled that were further imputed to the 1000 Genome Project Phase.<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref></p>
      <p id="p0120">We compared PRSs using Bayesian effect size estimates with three commonly used PRS methods: the standard method using informed LD pruning and p value thresholding (P + T),<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref><sup>,</sup><xref rid="bib50" ref-type="bibr"><sup>50</sup></xref> LDpred2,<xref rid="bib51" ref-type="bibr"><sup>51</sup></xref> and PRS-CS.<xref rid="bib52" ref-type="bibr"><sup>52</sup></xref> p value thresholds of <inline-formula><mml:math id="M51" altimg="si40.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>5</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:mn>5</mml:mn><mml:mo linebreak="badbreak">×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> and LD thresholds of <inline-formula><mml:math id="M52" altimg="si41.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>0.1</mml:mn><mml:mo>,</mml:mo><mml:mn>0.3</mml:mn><mml:mo>,</mml:mo><mml:mn>0.5</mml:mn><mml:mo>,</mml:mo><mml:mn>0.7</mml:mn><mml:mo>,</mml:mo><mml:mn>0.9</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> were considered by the P + T method. Reference LD derived from 1000 Genome data were used by the LDpred and PRS-CS methods. AD risk prediction accuracy was evaluated using the area under the receiver operating characteristic (ROC)<xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> curve (AUC) for MCADGC test samples.</p>
    </sec>
    <sec id="sec2.9">
      <title>Ethics statement</title>
      <p id="p0125">The ROS/MAP and MCADGS data analyzed in this study were generated with approval of the institutional review board (IRB) of Rush University Medical Center, Chicago, IL, and Mayo Clinic, respectively. All samples analyzed in this study were de-identified, and all analyses were approved by the IRB of Emory University School of Medicine.</p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Results</title>
    <sec id="sec3.1">
      <title>Simulation results</title>
      <p id="p0130">For all considered simulation scenarios, our Bayesian estimates of functional annotation enrichment achieved convergence with 4 EM iterations, as shown in boxplots of 100 simulation replicates (<xref rid="fig1" ref-type="fig">Figures 1</xref>A, 1D, and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>). Although BFGWAS_QUANT overestimated <inline-formula><mml:math id="M53" altimg="si42.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M54" altimg="si43.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, the Bayesian estimates still reflect the correct enrichment pattern among all considered annotations. By taking the 2.5th and 97.5th quantiles of these 100 Bayesian estimates to estimate the corresponding 2.5th and 97.5th quantiles of the estimator distributions, the true enrichment values <inline-formula><mml:math id="M55" altimg="si44.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>4</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.5em"/><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>1.5</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0.5</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>α</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo linebreak="badbreak">=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> indeed fell within this range. For example, in the scenario with <inline-formula><mml:math id="M56" altimg="si26.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:mn>10.5</mml:mn></mml:mrow></mml:math></inline-formula> and <inline-formula><mml:math id="M57" altimg="si45.gif"><mml:mrow><mml:msup><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.25</mml:mn></mml:mrow></mml:math></inline-formula> (<xref rid="fig1" ref-type="fig">Figure 1</xref>A), the estimated 2.5th and 97.5th quantiles are <inline-formula><mml:math id="M58" altimg="si46.gif"><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1.62</mml:mn><mml:mo>,</mml:mo><mml:mn>5.50</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula> for <inline-formula><mml:math id="M59" altimg="si42.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, (0.98, 4.57) for <inline-formula><mml:math id="M60" altimg="si43.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, (0.02, 1.20) for <inline-formula><mml:math id="M61" altimg="si47.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>, and (0.00, 0.38) for <inline-formula><mml:math id="M62" altimg="si48.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>. We observed precise estimates of 0 enrichment for the artificial annotation (<xref rid="fig1" ref-type="fig">Figures 1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>) and all annotations in the scenario with null enrichment (<xref rid="mmc1" ref-type="supplementary-material">Figure S3</xref>A), which demonstrated the ability of BFGWAS_QUANT to identify null enrichment.<fig id="fig1"><label>Figure 1</label><caption><p>Bayesian enrichment estimates, heritability estimates, and sensitivities of simulation studies.</p><p>(A–F) Simulations with <inline-formula><mml:math id="M63" altimg="si26.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:mn>10.5</mml:mn></mml:mrow></mml:math></inline-formula> (A–C) and simulations with <inline-formula><mml:math id="M64" altimg="si27.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mo linebreak="goodbreak" linebreakstyle="after">−</mml:mo><mml:mn>9.5</mml:mn></mml:mrow></mml:math></inline-formula> (D–F). Bayesian estimates of annotation enrichment (<inline-formula><mml:math id="M65" altimg="si51.gif"><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>α</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>α</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>α</mml:mi><mml:mn>4</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) of 100 simulations with true heritability <inline-formula><mml:math id="M66" altimg="si45.gif"><mml:mrow><mml:msup><mml:mi>h</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo linebreak="goodbreak" linebreakstyle="after">=</mml:mo><mml:mn>0.25</mml:mn></mml:mrow></mml:math></inline-formula> are shown in the respective boxplots (A and D), where red dots denote true enrichment values. Comparable heritability estimates (B and E) and higher sensitivities (C and F) were obtained by BFGWAS_QUANT (red) versus BVSR (blue).</p></caption><graphic xlink:href="gr1"/></fig></p>
      <p id="p0135">By taking PRS as estimated phenotypes and taking the squared correlation between RPS and simulated phenotypes as the estimate of phenotype heritability, we obtained similar heritability estimates by BFGWAS_QUANT and BVSR, which are close to the true heritability (<xref rid="fig1" ref-type="fig">Figures 1</xref>B, 1E, and <xref rid="mmc1" ref-type="supplementary-material">S3</xref>B). For scenarios with true enrichment, BFGWAS_QUANT obtained substantially higher sensitivity (power) and similar PPVs compared with BVSR for all scenarios (<xref rid="fig1" ref-type="fig">Figures 1</xref>C, 1F, <xref rid="mmc1" ref-type="supplementary-material">S2</xref>, <xref rid="mmc1" ref-type="supplementary-material">S4</xref>, and <xref rid="mmc1" ref-type="supplementary-material">S5</xref>). For the scenario with null enrichment, BFGWAS_QUANT and BVSR performed comparably (<xref rid="mmc1" ref-type="supplementary-material">Figures S3</xref>B–S3D).</p>
      <p id="p0140">These simulation studies validated the usefulness of BFGWAS_QUANT for quantifying multivariate functional annotations, estimating phenotype heritability, and identifying true causal SNPs. By accounting for multivariate quantitative annotations, BFGWAS_QUANT showed improved performance than the standard BVSR method, especially with higher power for identifying true causal SNPs and accurate enrichment estimation.</p>
    </sec>
    <sec id="sec3.2">
      <title>Application GWAS results for studying AD</title>
      <p id="p0145">Applying BFGWAS_QUANT to the individual-level ROS/MAP and summary-level IGAP GWAS data, we obtained consistent patterns for Bayesian enrichment estimates of 5 eQTL-based and 5 histone modification-based functional annotations (<xref rid="fig2" ref-type="fig">Figures 2</xref>, <xref rid="mmc1" ref-type="supplementary-material">S6</xref>, and <xref rid="mmc1" ref-type="supplementary-material">S7</xref>). In particular, the histone modification-based functional annotations had higher enrichment than eQTL-based annotations when studying the individual-level ROS/MAP GWAS data, with the highest enrichment for H3K27me3 and second highest for H3K4me1. BFGWAS_QUANT estimated the second highest enrichment for the Microglia_eQTL annotation when studying the summary-level IGAP GWAS data with a larger sample size (n = ∼54,000). Even with a small sample size in the individual-level ROS/MAP GWAS data, the Microglia_eQTL annotation was still identified with higher enrichment than other annotations based on eQTL of the bulk brain frontal cortex tissue. There is mounting evidence showing that microglia (composing &lt;10% cells in the bulk brain frontal cortex tissue) play important roles in development and progression of AD pathology,<xref rid="bib54" ref-type="bibr"><sup>54</sup></xref> and cell-type-specific differential expression of GWAS risk genes of AD is only present in microglia.<xref rid="bib55" ref-type="bibr"><sup>55</sup></xref><fig id="fig2"><label>Figure 2</label><caption><p>Bayesian estimates of functional annotation enrichment for Alzheimer dementia.</p><p>(A): Using ROS/MAP individual-level GWAS data and (B): Using IGAP summary-level GWAS data. Histone modification H3K27me3 (polycomb regression) and microglia <italic>cis</italic>-eQTL annotations were found to be most enriched for association signals of AD.</p></caption><graphic xlink:href="gr2"/></fig></p>
      <p id="p0150">Using the ROS/MAP individual-level GWAS data, four significant SNPs with Bayesian CPP greater than 0.1068 were identified for AD (rs429358, rs10414043, rs769449, and rs7256200) by BFGWAS_QUANT (<xref rid="tbl1" ref-type="table">Table 1</xref>; <xref rid="fig3" ref-type="fig">Figures 3</xref>A, <xref rid="mmc1" ref-type="supplementary-material">S8</xref>, and <xref rid="mmc1" ref-type="supplementary-material">S9</xref>). In particular, SNP rs429358 (CPP = 0.144, p = 7.72 × 10<sup>−13</sup>, missense variant) is the famous known <italic>APOE E4</italic> risk allele of AD<xref rid="bib56" ref-type="bibr"><sup>56</sup></xref> and has a significant Bayesian CPP greater than 0.1068 for all 5 AD related phenotypes. SNPs rs10414043 (CPP = 0.111, p = 2.71 × 10<sup>−12</sup>) and rs7256200 (CPP = 0.315, p = 2.71 × 10<sup>−12</sup>, regulatory variant) are upstream of the known risk gene <italic>APOC1</italic> of AD and blood protein traits.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref><sup>,</sup><xref rid="bib57" ref-type="bibr"><sup>57</sup></xref><sup>,</sup><xref rid="bib58" ref-type="bibr"><sup>58</sup></xref> Besides the missense <italic>APOE E4</italic> risk alleles rs429358 and rs7412, one additional significant SNP, rs1065853, is identified upstream of <italic>APOC1</italic> for global AD pathology, which is a known GWAS signal for blood protein traits such as low-density lipoprotein.<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref><sup>,</sup><xref rid="bib59" ref-type="bibr"><sup>59</sup></xref> Of 11 significant SNPs identified for at least one AD-related phenotype (<xref rid="tbl1" ref-type="table">Table 1</xref>), 2 are intergenic, and the other 9 SNPs are intron, regulatory, missense, and stop-gained variants.<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Significant SNPs with Bayesian CPP &gt;0.1068 by BFGWAS_QUANT for studying AD-related phenotypes using the ROS/MAP individual-level GWAS data</p></caption><table frame="hsides" rules="groups"><thead><tr><th>CHR</th><th>rsID</th><th>Gene</th><th>Function</th><th>MAF</th><th>CPP</th><th>Beta</th><th>p Value</th><th>Phenotype</th></tr></thead><tbody><tr><td>1</td><td>rs148348738<sup>a</sup></td><td>SPATA6</td><td>intron</td><td>0.011</td><td>0.149</td><td>−0.039</td><td>4.47E−07</td><td>cognition decline rate</td></tr><tr><td>2</td><td>rs147749419</td><td>CXCR1</td><td>regulatory</td><td>0.017</td><td>0.154</td><td>−0.043</td><td>2.94E−08</td><td>cognition decline rate</td></tr><tr><td>8</td><td>rs11787066<sup>a</sup></td><td>LOC<break/>107,986,930</td><td>intron</td><td>0.148</td><td>0.276</td><td>0.015</td><td>6.93E−08</td><td>β-amyloid</td></tr><tr><td>19</td><td>rs34134669<sup>a</sup></td><td>ADAMTS10</td><td>regulatory</td><td>0.234</td><td>0.119</td><td>−0.005</td><td>8.57E−07</td><td>cognition decline rate</td></tr><tr><td rowspan="3">19</td><td rowspan="3">rs769449</td><td rowspan="3">APOE<break/>TOMM40</td><td/><td>0.111</td><td>0.121</td><td>0.076</td><td>3.45E−11</td><td>Alzheimer dementia</td></tr><tr><td>regulatory</td><td>0.112</td><td>0.116</td><td>0.022</td><td>1.51E−16</td><td>tangle density</td></tr><tr><td/><td>0.109</td><td>0.475</td><td>−0.025</td><td>2.09E−15</td><td>cognition decline rate</td></tr><tr><td rowspan="5">19</td><td rowspan="5">rs429358</td><td rowspan="5">APOE</td><td/><td>0.138</td><td>0.144</td><td>0.037</td><td>7.72E−13</td><td>Alzheimer dementia</td></tr><tr><td/><td>0.138</td><td>0.631</td><td>0.037</td><td>1.17E−20</td><td>tangle density</td></tr><tr><td>missense</td><td>0.138</td><td>0.999</td><td>0.083</td><td>6.60E−27</td><td>β-amyloid</td></tr><tr><td/><td>0.139</td><td>0.999</td><td>0.089</td><td>1.19E−33</td><td>global AD pathology</td></tr><tr><td/><td>0.136</td><td>0.17</td><td>−0.036</td><td>1.29E−17</td><td>cognition decline rate</td></tr><tr><td>19</td><td>rs7412</td><td>APOE</td><td>missense</td><td>0.077</td><td>0.108</td><td>−0.027</td><td>6.67E−13</td><td>global AD pathology</td></tr><tr><td>19</td><td>rs1065853</td><td><italic>APOC1</italic></td><td>intergenic</td><td>0.076</td><td>0.381</td><td>−0.026</td><td>8.31E−13</td><td>global AD pathology</td></tr><tr><td>19</td><td>rs10414043</td><td><italic>APOC1</italic></td><td>intergenic</td><td>0.113</td><td>0.111</td><td>0.028</td><td>2.71E−12</td><td>Alzheimer dementia</td></tr><tr><td rowspan="3">19</td><td rowspan="3">rs7256200</td><td rowspan="3"><italic>APOC1</italic></td><td rowspan="3">regulatory</td><td>0.113</td><td>0.315</td><td>0.028</td><td>2.71E−12</td><td>Alzheimer dementia</td></tr><tr><td>0.113</td><td>0.228</td><td>0.03</td><td>3.86E−17</td><td>tangle density</td></tr><tr><td>0.111</td><td>0.270</td><td>−0.024</td><td>3.66E−15</td><td>cognition decline rate</td></tr><tr><td>20</td><td>rs1131695<xref rid="tbl1fn1" ref-type="table-fn">a</xref></td><td>APOC1</td><td>stop gained</td><td>0.435</td><td>0.119</td><td>0.039</td><td>1.06E−06</td><td>tangle density</td></tr></tbody></table><table-wrap-foot><fn id="tbl1fn1"><label>a</label><p id="ntpara0020">SNPs with a single variant test p value &gt;5 × 10<sup>−8</sup> that did not reach genome-wide significance by standard GWAS.</p></fn></table-wrap-foot></table-wrap><fig id="fig3"><label>Figure 3</label><caption><p>Manhattan plots of BFGWAS_QUANT results for studying Alzheimer dementia.</p><p>(A): Using ROS/MAP individual-level GWAS data; (B): Using IGAP summary-level GWAS data. Single-variant test p values were plotted in −log10 scale on the y axis. The dashed horizontal line denotes the genome-wide significant threshold <inline-formula><mml:math id="M67" altimg="si50.gif"><mml:mrow><mml:mn>5</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula>. SNPs with Bayesian CPP greater than 0.1068 were colored according to the color scale of their Bayesian CPP values by BFGWAS_QUANT. SNPs with Bayesian CPP greater than 0.5 were plotted as solid triangles.</p></caption><graphic xlink:href="gr3"/></fig></p>
      <p id="p0155">Using the IGAP summary-level GWAS data, BFGWAS_QUANT fine-mapped 32 significant SNPs with Bayesian CPP greater than 0.1068 associated with AD (<xref rid="tbl2" ref-type="table">Table 2</xref>; <xref rid="fig3" ref-type="fig">Figure 3</xref>B). Multiple SNPs located in genes <italic>PVRL2</italic>, <italic>APOE/TOMM40</italic>, and <italic>APOC1</italic> in chromosome 19 were found to be associated with AD with CPP = 1. Interestingly, 10 of 32 significant SNPs are <italic>cis</italic>-eQTL of microglia, and all significant SNPs except one intergenic SNP (rs7110631) are intron, regulatory, downstream, upstream, 3′ UTR, and missense variants (<xref rid="tbl2" ref-type="table">Table 2</xref>). All significant SNPs except rs78959900 are located in the peak regions of histone modification H3K27me3 (polycomb regression), which has the highest enrichment. Several SNPs that did not pass the genome-wide significance threshold (p &lt; 5 × 10<sup>−8</sup>) were identified by integrating 10 functional annotations in BFGWAS_QUANT. These SNPs are located in genes that have been found previously to be genetically linked to AD, such as <italic>HLA-DRB1</italic>, <italic>NUP160</italic>, <italic>SLC24A4</italic>, and <italic>CD33</italic>.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref><sup>,</sup><xref rid="bib56" ref-type="bibr"><sup>56</sup></xref><sup>,</sup><xref rid="bib60" ref-type="bibr">60</xref>, <xref rid="bib61" ref-type="bibr">61</xref>, <xref rid="bib62" ref-type="bibr">62</xref>, <xref rid="bib63" ref-type="bibr">63</xref><table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>Significant SNPs with Bayesian CPP &gt; 0.1068 by BFGWAS_QUANT for studying AD using the IGAP summary-level GWAS data</p></caption><table frame="hsides" rules="groups"><thead><tr><th>CHR</th><th>rsID</th><th>Gene</th><th>Function</th><th>CPP</th><th>Beta</th><th>p Value</th></tr></thead><tbody><tr><td>1</td><td>rs6656401</td><td>CR1</td><td>intron</td><td>0.119</td><td>−0.017</td><td>8.67E−15</td></tr><tr><td>1</td><td>rs7515905</td><td>CR1</td><td>intron</td><td>0.206</td><td>−0.019</td><td>3.75E−15</td></tr><tr><td>1</td><td>rs1752684</td><td>CR1</td><td>regulatory</td><td>0.125</td><td>−0.017</td><td>3.77E−15</td></tr><tr><td>1</td><td>rs679515</td><td>CR1</td><td>intron</td><td>0.220</td><td>−0.018</td><td>3.60E−15</td></tr><tr><td>2</td><td>rs4663105</td><td>BIN1</td><td>regulatory</td><td>0.631</td><td>0.050</td><td>1.26E−26</td></tr><tr><td>2</td><td>rs6733839</td><td>BIN1</td><td>regulatory</td><td>0.796</td><td>0.053</td><td>1.24E−26</td></tr><tr><td>6</td><td>rs9270999<sup>a</sup></td><td>HLA-DRB1</td><td>intron</td><td>0.181</td><td>0.001</td><td>8.04E−08</td></tr><tr><td>6</td><td>rs9273472<sup>a</sup></td><td>HLA-DRB1</td><td>intron</td><td>0.110</td><td>0.074</td><td>1.63E−04</td></tr><tr><td>7</td><td>rs10808026</td><td>EPHA1</td><td>intron</td><td>0.123</td><td>−0.020</td><td>1.36E−11</td></tr><tr><td>7</td><td>rs11762262</td><td>EPHA1</td><td>intron</td><td>0.117</td><td>−0.011</td><td>2.21E−10</td></tr><tr><td>7</td><td>rs11763230</td><td>EPHA1</td><td>intron</td><td>0.325</td><td>−0.020</td><td>1.86E−11</td></tr><tr><td>7</td><td>rs11771145</td><td>EPHA1</td><td>intron</td><td>0.173</td><td>−0.021</td><td>8.69E−10</td></tr><tr><td>8</td><td>rs28834970</td><td>PTK2B</td><td>intron</td><td>0.137</td><td>0.066</td><td>3.22E−09</td></tr><tr><td>8</td><td>rs2279590</td><td>CLU</td><td>intron</td><td>0.166</td><td>0.021</td><td>4.47E−17</td></tr><tr><td>8</td><td>rs4236673</td><td>CLU</td><td>intron</td><td>0.123</td><td>0.020</td><td>3.25E−17</td></tr><tr><td>8</td><td>rs11787077</td><td>CLU</td><td>intron</td><td>0.247</td><td>0.022</td><td>2.94E−17</td></tr><tr><td>8</td><td>rs9331896</td><td>CLU</td><td>intron</td><td>0.154</td><td>0.022</td><td>8.38E−17</td></tr><tr><td>8</td><td>rs2070926</td><td>CLU</td><td>intron</td><td>0.278</td><td>0.023</td><td>2.69E−17</td></tr><tr><td>11</td><td>rs11039390<sup>a</sup></td><td>NUP160</td><td>downstream</td><td>0.145</td><td>−0.004</td><td>2.31E−05</td></tr><tr><td>11</td><td>rs4939338</td><td>MS4A6E</td><td>upstream</td><td>0.139</td><td>0.011</td><td>2.79E−12</td></tr><tr><td>11</td><td>rs7110631</td><td>PICALM</td><td>intergenic</td><td>0.134</td><td>0.014</td><td>8.77E−15</td></tr><tr><td>11</td><td>rs10792832</td><td>RNU6-560P</td><td>regulatory</td><td>0.633</td><td>0.027</td><td>7.89E−16</td></tr><tr><td>11</td><td>rs11218343</td><td>SORL1</td><td>regulatory</td><td>0.643</td><td>−0.046</td><td>4.77E−11</td></tr><tr><td>14</td><td>rs10498633<sup>a</sup></td><td>SLC24A4</td><td>intron</td><td>0.371</td><td>−0.059</td><td>1.55E−07</td></tr><tr><td>19</td><td>rs3752246</td><td>ABCA7</td><td>missense</td><td>0.361</td><td>−0.027</td><td>4.27E−09</td></tr><tr><td>19</td><td>rs4147929</td><td>ABCA7</td><td>regulatory</td><td>0.111</td><td>−0.030</td><td>1.77E−09</td></tr><tr><td>19</td><td>rs41289512</td><td>PVRL2</td><td>regulatory</td><td>1.000</td><td>0.132</td><td>1.81E−167</td></tr><tr><td>19</td><td>rs6857</td><td>PVRL2</td><td>3′ UTR</td><td>1.000</td><td>0.359</td><td>0</td></tr><tr><td>19</td><td>rs769449</td><td>APOE/TOMM40</td><td>regulatory</td><td>1.000</td><td>0.292</td><td>0</td></tr><tr><td>19</td><td>rs56131196</td><td>APOC1</td><td>regulatory</td><td>1.000</td><td>0.251</td><td>0</td></tr><tr><td>19</td><td>rs78959900</td><td>APOC1</td><td>downstream</td><td>1.000</td><td>−0.096</td><td>8.22E−85</td></tr><tr><td>19</td><td>rs12459419<sup>a</sup></td><td>CD33</td><td>missense</td><td>0.245</td><td>−0.027</td><td>6.66E−08</td></tr></tbody></table><table-wrap-foot><fn><p>a: SNPs with single-variant test p value &gt;5 × 10<sup>−8</sup> that did not reach genome-wide significance by standard GWAS.</p></fn></table-wrap-foot></table-wrap></p>
      <p id="p0160">The summation of genome-wide Bayesian CPP of SNPs with CPP greater than 0.01 can be used to estimate the number of total causal SNPs for the phenotype of interest. The threshold of CPP &gt;0.01 is used to exclude adding CPP from random MCMC selections. Although the power is limited for analyzing the ROS/MAP individual-level GWAS data with a small sample size, BFGWAS_QUANT estimated a total of 54 potential causal SNPs for AD using the IGAP summary-level GWAS data (<xref rid="tbl3" ref-type="table">Table 3</xref>).<table-wrap position="float" id="tbl3"><label>Table 3</label><caption><p>Estimates of total causal SNPs</p></caption><table frame="hsides" rules="groups"><thead><tr><th>GWAS data</th><th>Phenotype</th><th>BFGWAS_QUANT</th><th>BVSR<xref rid="tblfn1" ref-type="table-fn">a</xref></th></tr></thead><tbody><tr><td rowspan="5">ROS/MAP</td><td>Alzheimer dementia</td><td>0.718</td><td>6.472</td></tr><tr><td>tangle density</td><td>3.179</td><td>6.127</td></tr><tr><td><italic>β</italic>-amyloid</td><td>5.375</td><td>7.316</td></tr><tr><td>global AD pathology</td><td>5.375</td><td>6.174</td></tr><tr><td>cognition decline rate</td><td>6.219</td><td>7.136</td></tr><tr><td>IGAP</td><td>Alzheimer dementia</td><td>54.282</td><td>–</td></tr></tbody></table><table-wrap-foot><fn><p>The summations of the Bayesian CPP estimates of SNPs with CPP &gt;0.01 estimate the total number of causal SNPs.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tblfn1"><label>a</label><p id="ntpara0015">BVSR was not developed for using summary-level GWAS data.</p></fn></table-wrap-foot></table-wrap></p>
    </sec>
    <sec id="sec3.3">
      <title>AD risk prediction by PRS in MCADGS</title>
      <p id="p0165">To show the usefulness of BFGWAS_QUANT for studying complex traits and diseases, we derived a PRS using the Bayesian effect size estimates by BFGWAS_QUANT for an independent GWAS cohort, MCADGS (n = 2,099), and compared the risk prediction accuracy with the PRS using effect size estimates by BVSR, P + T, LDpred2, and PRS-CS. When the ROS/MAP individual-level GWAS data were used as training data, a comparable AUC was obtained by using Bayesian effect size estimates by BFGWAS_QUANT (0.69) and BVSR (0.68), which was similar to the one obtained by LDpred2-auto (0.68) but significantly higher than the ones obtained by P + T (0.55), LDpred2-inf (0.53), and PRS-CS (0.54) (<xref rid="fig4" ref-type="fig">Figure 4</xref>A). This showed the advantage of deriving PRSs using Bayesian effect size estimates by BFGWAS_QUANT when individual-level GWAS data are available, especially when the sample size is small. When the IGAP summary-level GWAS data were used as training data, the AUC by BFGWAS_QUANT (0.75) was the same as by LDpred2-auto (0.75) but much lower than P + T (0.88 with a p value threshold of <inline-formula><mml:math id="M68" altimg="si49.gif"><mml:mrow><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula>), LDpred2-inf (0.94), and PRS-CS (0.93) (<xref rid="fig4" ref-type="fig">Figure 4</xref>B). These results show that an infinitesimal model<xref rid="bib64" ref-type="bibr"><sup>64</sup></xref> as assumed by PRS-CS and LDpred2-inf is more suitable for PRS development than the sparse model assumed by BFGWAS_QUANT and LDpred2-auto.<fig id="fig4"><label>Figure 4</label><caption><p>ROC plots comparing prediction accuracy of Alzheimer dementia in the test data of MCDGC.</p><p>(A): PRSs derived using the ROS/MAP individual-level GWAS data; (B): PRSs derived using IGAP summary-level GWAS data . The PRS derived using Bayesian effect size estimates by BFGWAS_QUANT has comparable prediction accuracy as the PRSs derived by BVSR and LDpred2 auto, for all assuming a sparse causal model. PRSs derived by PRS-CS and LDpred2-inf using IGAP summary-level GWAS data as training data have the highest prediction accuracy for assuming an infinitesimal causal model.</p></caption><graphic xlink:href="gr4"/></fig></p>
    </sec>
  </sec>
  <sec id="sec4">
    <title>Discussion</title>
    <p id="p0170">We developed a scalable BFGWAS method to account for multivariate quantitative functional annotations (BFGWAS_QUANT) for studying complex traits and diseases based on a hierarchical BVSR model and accompanied by a scalable EM-MCMC computation algorithm. BFGWAS_QUANT has the advantages of quantifying enrichment of functional annotations as well as modeling LD to generate fine-mapped GWAS results that are also prioritized based on their functional annotations. BFGWAS_QUANT can be applied to individual-level and summary-level GWAS data. In particular, the Bayesian effect size estimates can be used to derive a PRS that accounts for functional annotations.</p>
    <p id="p0175">Our simulation studies validated the performance of BFGWAS_QUANT with respect to annotation enrichment quantification, GWAS association identification, and heritability estimation. Compared with BVSR, the BFGWAS_QUANT method had higher sensitivity (i.e., power) and comparable PPV and accuracy of phenotype heritability estimation.</p>
    <p id="p0180">In real studies of AD-related phenotypes using ROS/MAP individual-level and IGAP summary-level GWAS data, we showed that interesting enrichment patterns were identified, fine-mapped GWAS signals were identified, and predictive PRSs were derived. In particular, we found that the histone modification H3K27me3 (polycomb regression) and microglia <italic>cis</italic>-eQTL annotations were most enriched for association signals of AD. We also showed that SNPs with single variant test p values &lt; <inline-formula><mml:math id="M69" altimg="si50.gif"><mml:mrow><mml:mn>5</mml:mn><mml:mo linebreak="goodbreak" linebreakstyle="after">×</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula>could be identified for being prioritized because of their functional annotations.</p>
    <p id="p0185">Despite these advantages, BFGWAS_QUANT does have its limitations. First, the BFGWAS_QUANT model was developed for quantitative traits. However, following previous studies,<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="bib65" ref-type="bibr"><sup>65</sup></xref> GWAS analysis can still be done for dichotomous traits by quantifying cases as 1 and controls as 0, which will have a similar performance as a probit model when samples are independent and population structure can be addressed by top genotype principal components. Extending the BFGWAS_QUANT method for studying dichotomous traits is also part of our ongoing research. Second, BFGWAS_QUANT assumes the summary-level GWAS data, and reference LDs were derived from populations of the same ancestry. BFGWAS_QUANT per ancestry needs to be applied first, and then the results have to be meta-analyzed for studying GWAS cohorts with multiple ancestries. Third, BFGWAS_QUANT assumes a sparse causal genetic architecture that is suitable for generating fine-mapped GWAS results but might lack of power for deriving PRS for complex traits and diseases.</p>
    <p id="p0190">Our work demonstrated the usefulness of integrating multivariate quantitative functional annotations in GWASs for quantifying the enrichment of multiple functional annotations and generating fine-mapped GWAS results with higher power. Specifically, accurate quantification of annotation enrichment would help prioritize GWAS signals (fine-mapping) and then help illustrate the underlying genomic etiology of complex traits and diseases. Because publicly available molecular QTL datasets, epigenomic features, and GWAS summary data continue to grow, BFGWAS_QUANT provides a convenient tool for integrative multi-omics analyses of these datasets.</p>
  </sec>
  <sec sec-type="data-availability" id="sec5">
    <title>Data and code availability</title>
    <p id="p0195">ROS/MAP data can be requested through Rush Alzheimer’s Disease Center (<ext-link ext-link-type="uri" xlink:href="http://www.radc.rush.edu/" id="intref0010">http://www.radc.rush.edu/</ext-link>) and Synapse:syn3219045 (<ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn3219045" id="intref0015">https://www.synapse.org/#!Synapse:syn3219045</ext-link>). MCADGS data can be requested through Synapse:syn2910256 (<ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn2910256" id="intref0020">https://www.synapse.org/#!Synapse:syn2910256</ext-link>). IGAP summary statistics are available from IGAP:<ext-link ext-link-type="uri" xlink:href="http://web.pasteur-lille.fr/en/recherche/u744/igap/igap_download.php" id="intref0025">http://web.pasteur-lille.fr/en/recherche/u744/igap/igap_download.php</ext-link>. Annotations derived from <italic>cis</italic>-eQTL of brain frontal cortex tissue are available from LDSC_QTL:<ext-link ext-link-type="uri" xlink:href="https://alkesgroup.broadinstitute.org/LDSCORE/LDSC_QTL/" id="intref0030">https://alkesgroup.broadinstitute.org/LDSCORE/LDSC_QTL/</ext-link>. <italic>cis</italic>-eQTL data of microglia are available from Zenodo:6104982 (<ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/6104982" id="intref0035">https://zenodo.org/record/6104982</ext-link>) and Zenodo:4118605 (<ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/4118605" id="intref0040">https://zenodo.org/record/4118605</ext-link>). Source code of BFGWAS_QUANT is available through Github (<ext-link ext-link-type="uri" xlink:href="https://github.com/yanglab-emory/BFGWAS_QUANT" id="intref0045">https://github.com/yanglab-emory/BFGWAS_QUANT</ext-link>).</p>
  </sec>
</body>
<back>
  <ref-list id="cebib0010">
    <title>References</title>
    <ref id="bib1">
      <label>1</label>
      <element-citation publication-type="journal" id="sref1">
        <person-group person-group-type="author">
          <name>
            <surname>Visscher</surname>
            <given-names>P.M.</given-names>
          </name>
          <name>
            <surname>Wray</surname>
            <given-names>N.R.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Sklar</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>McCarthy</surname>
            <given-names>M.I.</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>M.A.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>10 years of GWAS discovery: biology, function, and translation</article-title>
        <source>Am. J. Hum. Genet.</source>
        <volume>101</volume>
        <year>2017</year>
        <fpage>5</fpage>
        <lpage>22</lpage>
        <pub-id pub-id-type="pmid">28686856</pub-id>
      </element-citation>
    </ref>
    <ref id="bib2">
      <label>2</label>
      <element-citation publication-type="journal" id="sref2">
        <person-group person-group-type="author">
          <name>
            <surname>Welter</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>MacArthur</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Morales</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Burdett</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Junkins</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Klemm</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Flicek</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Manolio</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Hindorff</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Parkinson</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>The NHGRI GWAS catalog, a curated resource of SNP-trait associations</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>42</volume>
        <year>2014</year>
        <fpage>D1001</fpage>
        <lpage>D1006</lpage>
        <pub-id pub-id-type="pmid">24316577</pub-id>
      </element-citation>
    </ref>
    <ref id="bib3">
      <label>3</label>
      <element-citation publication-type="journal" id="sref3">
        <person-group person-group-type="author">
          <name>
            <surname>McCarthy</surname>
            <given-names>M.I.</given-names>
          </name>
          <name>
            <surname>Abecasis</surname>
            <given-names>G.R.</given-names>
          </name>
          <name>
            <surname>Cardon</surname>
            <given-names>L.R.</given-names>
          </name>
          <name>
            <surname>Goldstein</surname>
            <given-names>D.B.</given-names>
          </name>
          <name>
            <surname>Little</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>J.P.A.</given-names>
          </name>
          <name>
            <surname>Hirschhorn</surname>
            <given-names>J.N.</given-names>
          </name>
        </person-group>
        <article-title>Genome-wide association studies for complex traits: consensus, uncertainty and challenges</article-title>
        <source>Nat. Rev. Genet.</source>
        <volume>9</volume>
        <year>2008</year>
        <fpage>356</fpage>
        <lpage>369</lpage>
        <pub-id pub-id-type="pmid">18398418</pub-id>
      </element-citation>
    </ref>
    <ref id="bib4">
      <label>4</label>
      <element-citation publication-type="journal" id="sref4">
        <person-group person-group-type="author">
          <name>
            <surname>Hindorff</surname>
            <given-names>L.A.</given-names>
          </name>
          <name>
            <surname>Sethupathy</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Junkins</surname>
            <given-names>H.A.</given-names>
          </name>
          <name>
            <surname>Ramos</surname>
            <given-names>E.M.</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>J.P.</given-names>
          </name>
          <name>
            <surname>Collins</surname>
            <given-names>F.S.</given-names>
          </name>
          <name>
            <surname>Manolio</surname>
            <given-names>T.A.</given-names>
          </name>
        </person-group>
        <article-title>Potential etiologic and functional implications of genome-wide association loci for human diseases and traits</article-title>
        <source>Proc. Natl. Acad. Sci. USA</source>
        <volume>106</volume>
        <year>2009</year>
        <fpage>9362</fpage>
        <lpage>9367</lpage>
        <pub-id pub-id-type="pmid">19474294</pub-id>
      </element-citation>
    </ref>
    <ref id="bib5">
      <label>5</label>
      <element-citation publication-type="journal" id="sref5">
        <person-group person-group-type="author">
          <name>
            <surname>Gallagher</surname>
            <given-names>M.D.</given-names>
          </name>
          <name>
            <surname>Chen-Plotkin</surname>
            <given-names>A.S.</given-names>
          </name>
        </person-group>
        <article-title>The post-GWAS era: from association to function</article-title>
        <source>Am. J. Hum. Genet.</source>
        <volume>102</volume>
        <year>2018</year>
        <fpage>717</fpage>
        <lpage>730</lpage>
        <pub-id pub-id-type="pmid">29727686</pub-id>
      </element-citation>
    </ref>
    <ref id="bib6">
      <label>6</label>
      <element-citation publication-type="journal" id="sref6">
        <person-group person-group-type="author">
          <name>
            <surname>Rentzsch</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Witten</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>G.M.</given-names>
          </name>
          <name>
            <surname>Shendure</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Kircher</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>CADD: predicting the deleteriousness of variants throughout the human genome</article-title>
        <source>Nucleic Acids Res.</source>
        <volume>47</volume>
        <year>2019</year>
        <fpage>D886</fpage>
        <lpage>D894</lpage>
        <pub-id pub-id-type="pmid">30371827</pub-id>
      </element-citation>
    </ref>
    <ref id="bib7">
      <label>7</label>
      <element-citation publication-type="journal" id="sref7">
        <person-group person-group-type="author">
          <collab>Roadmap Epigenomics Consortium</collab>
          <name>
            <surname>Kundaje</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Meuleman</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Ernst</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Bilenky</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Heravi-Moussavi</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Kheradpour</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrative analysis of 111 reference human epigenomes</article-title>
        <source>Nature</source>
        <volume>518</volume>
        <year>2015</year>
        <fpage>317</fpage>
        <lpage>330</lpage>
        <pub-id pub-id-type="pmid">25693563</pub-id>
      </element-citation>
    </ref>
    <ref id="bib8">
      <label>8</label>
      <element-citation publication-type="journal" id="sref8">
        <person-group person-group-type="author">
          <collab>The ENCODE Project Consortium</collab>
        </person-group>
        <article-title>A user's guide to the encyclopedia of DNA elements (ENCODE)</article-title>
        <source>PLoS Biol.</source>
        <volume>9</volume>
        <year>2011</year>
        <fpage>e1001046</fpage>
        <pub-id pub-id-type="pmid">21526222</pub-id>
      </element-citation>
    </ref>
    <ref id="bib9">
      <label>9</label>
      <element-citation publication-type="journal" id="sref9">
        <person-group person-group-type="author">
          <collab>The GTEx Consortium</collab>
        </person-group>
        <article-title>The GTEx Consortium atlas of genetic regulatory effects across human tissues</article-title>
        <source>Science</source>
        <volume>369</volume>
        <year>2020</year>
        <fpage>1318</fpage>
        <lpage>1330</lpage>
        <pub-id pub-id-type="pmid">32913098</pub-id>
      </element-citation>
    </ref>
    <ref id="bib10">
      <label>10</label>
      <element-citation publication-type="journal" id="sref10">
        <person-group person-group-type="author">
          <name>
            <surname>McVicker</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>van de Geijn</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Degner</surname>
            <given-names>J.F.</given-names>
          </name>
          <name>
            <surname>Cain</surname>
            <given-names>C.E.</given-names>
          </name>
          <name>
            <surname>Banovich</surname>
            <given-names>N.E.</given-names>
          </name>
          <name>
            <surname>Raj</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Lewellen</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Myrthil</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Gilad</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Pritchard</surname>
            <given-names>J.K.</given-names>
          </name>
        </person-group>
        <article-title>Identification of genetic variants that affect histone modifications in human cells</article-title>
        <source>Science</source>
        <volume>342</volume>
        <year>2013</year>
        <fpage>747</fpage>
        <lpage>749</lpage>
        <pub-id pub-id-type="pmid">24136359</pub-id>
      </element-citation>
    </ref>
    <ref id="bib11">
      <label>11</label>
      <element-citation publication-type="journal" id="sref11">
        <person-group person-group-type="author">
          <name>
            <surname>Ernst</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Kellis</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Discovery and characterization of chromatin states for systematic annotation of the human genome</article-title>
        <source>Nat. Biotechnol.</source>
        <volume>28</volume>
        <year>2010</year>
        <fpage>817</fpage>
        <lpage>825</lpage>
        <pub-id pub-id-type="pmid">20657582</pub-id>
      </element-citation>
    </ref>
    <ref id="bib12">
      <label>12</label>
      <element-citation publication-type="journal" id="sref12">
        <person-group person-group-type="author">
          <name>
            <surname>Robins</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Duong</surname>
            <given-names>D.M.</given-names>
          </name>
          <name>
            <surname>Meigs</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Harerimana</surname>
            <given-names>N.V.</given-names>
          </name>
          <name>
            <surname>Gerasimov</surname>
            <given-names>E.S.</given-names>
          </name>
          <name>
            <surname>Dammer</surname>
            <given-names>E.B.</given-names>
          </name>
          <name>
            <surname>Cutler</surname>
            <given-names>D.J.</given-names>
          </name>
          <name>
            <surname>Beach</surname>
            <given-names>T.G.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic control of the human brain proteome</article-title>
        <source>Am. J. Hum. Genet.</source>
        <volume>108</volume>
        <year>2021</year>
        <fpage>400</fpage>
        <lpage>410</lpage>
        <pub-id pub-id-type="pmid">33571421</pub-id>
      </element-citation>
    </ref>
    <ref id="bib13">
      <label>13</label>
      <element-citation publication-type="journal" id="sref13">
        <person-group person-group-type="author">
          <name>
            <surname>Banovich</surname>
            <given-names>N.E.</given-names>
          </name>
          <name>
            <surname>Lan</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>McVicker</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>van de Geijn</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Degner</surname>
            <given-names>J.F.</given-names>
          </name>
          <name>
            <surname>Blischak</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Roux</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Pritchard</surname>
            <given-names>J.K.</given-names>
          </name>
          <name>
            <surname>Gilad</surname>
            <given-names>Y.</given-names>
          </name>
        </person-group>
        <article-title>Methylation QTLs are associated with coordinated changes in transcription factor binding, histone modifications, and gene expression levels</article-title>
        <source>PLoS Genet.</source>
        <volume>10</volume>
        <year>2014</year>
        <fpage>e1004663</fpage>
        <pub-id pub-id-type="pmid">25233095</pub-id>
      </element-citation>
    </ref>
    <ref id="bib14">
      <label>14</label>
      <element-citation publication-type="journal" id="sref14">
        <person-group person-group-type="author">
          <name>
            <surname>Waszak</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Delaneau</surname>
            <given-names>O.</given-names>
          </name>
          <name>
            <surname>Gschwind</surname>
            <given-names>A.R.</given-names>
          </name>
          <name>
            <surname>Kilpinen</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Raghav</surname>
            <given-names>S.K.</given-names>
          </name>
          <name>
            <surname>Witwicki</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Orioli</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Wiederkehr</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Panousis</surname>
            <given-names>N.I.</given-names>
          </name>
          <name>
            <surname>Yurovsky</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Population variation and genetic control of modular chromatin architecture in humans</article-title>
        <source>Cell</source>
        <volume>162</volume>
        <year>2015</year>
        <fpage>1039</fpage>
        <lpage>1050</lpage>
        <pub-id pub-id-type="pmid">26300124</pub-id>
      </element-citation>
    </ref>
    <ref id="bib15">
      <label>15</label>
      <element-citation publication-type="journal" id="sref15">
        <person-group person-group-type="author">
          <name>
            <surname>Heyn</surname>
            <given-names>H.</given-names>
          </name>
        </person-group>
        <article-title>Quantitative trait loci identify functional noncoding variation in cancer</article-title>
        <source>PLoS Genet.</source>
        <volume>12</volume>
        <year>2016</year>
        <fpage>e1005826</fpage>
        <pub-id pub-id-type="pmid">26938653</pub-id>
      </element-citation>
    </ref>
    <ref id="bib16">
      <label>16</label>
      <element-citation publication-type="journal" id="sref16">
        <person-group person-group-type="author">
          <name>
            <surname>Hormozdiari</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Kostem</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>E.Y.</given-names>
          </name>
          <name>
            <surname>Pasaniuc</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Eskin</surname>
            <given-names>E.</given-names>
          </name>
        </person-group>
        <article-title>Identifying causal variants at loci with multiple signals of association</article-title>
        <source>Genetics</source>
        <volume>198</volume>
        <year>2014</year>
        <fpage>497</fpage>
        <lpage>508</lpage>
        <pub-id pub-id-type="pmid">25104515</pub-id>
      </element-citation>
    </ref>
    <ref id="bib17">
      <label>17</label>
      <element-citation publication-type="journal" id="sref17">
        <person-group person-group-type="author">
          <name>
            <surname>Le</surname>
            <given-names>K.T.T.</given-names>
          </name>
          <name>
            <surname>Matzaraki</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Netea</surname>
            <given-names>M.G.</given-names>
          </name>
          <name>
            <surname>Wijmenga</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Moser</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>V.</given-names>
          </name>
        </person-group>
        <article-title>Functional annotation of genetic loci associated with sepsis prioritizes immune and endothelial cell pathways</article-title>
        <source>Front. Immunol.</source>
        <volume>10</volume>
        <year>2019</year>
        <fpage>1949</fpage>
        <pub-id pub-id-type="pmid">31475010</pub-id>
      </element-citation>
    </ref>
    <ref id="bib18">
      <label>18</label>
      <element-citation publication-type="journal" id="sref18">
        <person-group person-group-type="author">
          <name>
            <surname>Matzaraki</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Gresnigt</surname>
            <given-names>M.S.</given-names>
          </name>
          <name>
            <surname>Jaeger</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Ricaño-Ponce</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>M.D.</given-names>
          </name>
          <name>
            <surname>Oosting</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Franke</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Withoff</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Perfect</surname>
            <given-names>J.R.</given-names>
          </name>
          <name>
            <surname>Joosten</surname>
            <given-names>L.A.B.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An integrative genomics approach identifies novel pathways that influence candidaemia susceptibility</article-title>
        <source>PLoS One</source>
        <volume>12</volume>
        <year>2017</year>
        <fpage>e0180824</fpage>
        <pub-id pub-id-type="pmid">28727728</pub-id>
      </element-citation>
    </ref>
    <ref id="bib19">
      <label>19</label>
      <element-citation publication-type="journal" id="sref19">
        <person-group person-group-type="author">
          <name>
            <surname>Ruffieux</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Fairfax</surname>
            <given-names>B.P.</given-names>
          </name>
          <name>
            <surname>Nassiri</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Vigorito</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Bottolo</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>EPISPOT: an epigenome-driven approach for detecting and interpreting hotspots in molecular QTL studies</article-title>
        <source>Am. J. Hum. Genet.</source>
        <volume>108</volume>
        <year>2021</year>
        <fpage>983</fpage>
        <lpage>1000</lpage>
        <pub-id pub-id-type="pmid">33909991</pub-id>
      </element-citation>
    </ref>
    <ref id="bib20">
      <label>20</label>
      <element-citation publication-type="journal" id="sref20">
        <person-group person-group-type="author">
          <name>
            <surname>Nicolae</surname>
            <given-names>D.L.</given-names>
          </name>
          <name>
            <surname>Gamazon</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Dolan</surname>
            <given-names>M.E.</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>N.J.</given-names>
          </name>
        </person-group>
        <article-title>Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS</article-title>
        <source>PLoS Genet.</source>
        <volume>6</volume>
        <year>2010</year>
        <fpage>e1000888</fpage>
        <pub-id pub-id-type="pmid">20369019</pub-id>
      </element-citation>
    </ref>
    <ref id="bib21">
      <label>21</label>
      <element-citation publication-type="journal" id="sref21">
        <person-group person-group-type="author">
          <name>
            <surname>Ng</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>C.C.</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>H.U.</given-names>
          </name>
          <name>
            <surname>Sieberts</surname>
            <given-names>S.K.</given-names>
          </name>
          <name>
            <surname>McCabe</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Patrick</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Gaiteri</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Bennett</surname>
            <given-names>D.A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome</article-title>
        <source>Nat. Neurosci.</source>
        <volume>20</volume>
        <year>2017</year>
        <fpage>1418</fpage>
        <lpage>1426</lpage>
        <pub-id pub-id-type="pmid">28869584</pub-id>
      </element-citation>
    </ref>
    <ref id="bib22">
      <label>22</label>
      <element-citation publication-type="journal" id="sref22">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Fritsche</surname>
            <given-names>L.G.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Abecasis</surname>
            <given-names>G.</given-names>
          </name>
          <collab>International Age-Related Macular Degeneration Genomics Consortium</collab>
        </person-group>
        <article-title>A scalable bayesian method for integrating functional information in genome-wide association studies</article-title>
        <source>Am. J. Hum. Genet.</source>
        <volume>101</volume>
        <year>2017</year>
        <fpage>404</fpage>
        <lpage>416</lpage>
        <pub-id pub-id-type="pmid">28844487</pub-id>
      </element-citation>
    </ref>
    <ref id="bib23">
      <label>23</label>
      <element-citation publication-type="journal" id="sref23">
        <person-group person-group-type="author">
          <name>
            <surname>Pickrell</surname>
            <given-names>J.K.</given-names>
          </name>
        </person-group>
        <article-title>Joint analysis of functional genomic data and genome-wide association studies of 18 human traits</article-title>
        <source>Am. J. Hum. Genet.</source>
        <volume>94</volume>
        <year>2014</year>
        <fpage>559</fpage>
        <lpage>573</lpage>
        <pub-id pub-id-type="pmid">24702953</pub-id>
      </element-citation>
    </ref>
    <ref id="bib24">
      <label>24</label>
      <element-citation publication-type="journal" id="sref24">
        <person-group person-group-type="author">
          <name>
            <surname>Trynka</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Westra</surname>
            <given-names>H.-J.</given-names>
          </name>
          <name>
            <surname>Slowikowski</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Stranger</surname>
            <given-names>B.E.</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>R.J.</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Raychaudhuri</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Disentangling the effects of colocalizing genomic annotations to functionally prioritize non-coding variants within complex-trait loci</article-title>
        <source>Am. J. Hum. Genet.</source>
        <volume>97</volume>
        <year>2015</year>
        <fpage>139</fpage>
        <lpage>152</lpage>
        <pub-id pub-id-type="pmid">26140449</pub-id>
      </element-citation>
    </ref>
    <ref id="bib25">
      <label>25</label>
      <element-citation publication-type="journal" id="sref25">
        <person-group person-group-type="author">
          <name>
            <surname>Iversen</surname>
            <given-names>E.S.</given-names>
          </name>
          <name>
            <surname>Lipton</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Clyde</surname>
            <given-names>M.A.</given-names>
          </name>
          <name>
            <surname>Monteiro</surname>
            <given-names>A.N.A.</given-names>
          </name>
        </person-group>
        <article-title>Functional annotation signatures of disease susceptibility loci improve SNP association analysis</article-title>
        <source>BMC Genom.</source>
        <volume>15</volume>
        <year>2014</year>
        <fpage>398</fpage>
      </element-citation>
    </ref>
    <ref id="bib26">
      <label>26</label>
      <element-citation publication-type="journal" id="sref26">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>G.K.</given-names>
          </name>
          <name>
            <surname>Witte</surname>
            <given-names>J.S.</given-names>
          </name>
        </person-group>
        <article-title>Enriching the analysis of genomewide association studies with hierarchical modeling</article-title>
        <source>Am. J. Hum. Genet.</source>
        <volume>81</volume>
        <year>2007</year>
        <fpage>397</fpage>
        <lpage>404</lpage>
        <pub-id pub-id-type="pmid">17668389</pub-id>
      </element-citation>
    </ref>
    <ref id="bib27">
      <label>27</label>
      <element-citation publication-type="journal" id="sref27">
        <person-group person-group-type="author">
          <name>
            <surname>Kichaev</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>W.-Y.</given-names>
          </name>
          <name>
            <surname>Lindstrom</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Hormozdiari</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Eskin</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Price</surname>
            <given-names>A.L.</given-names>
          </name>
          <name>
            <surname>Kraft</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Pasaniuc</surname>
            <given-names>B.</given-names>
          </name>
        </person-group>
        <article-title>Integrating functional data to prioritize causal variants in statistical fine-mapping studies</article-title>
        <source>PLoS Genet.</source>
        <volume>10</volume>
        <year>2014</year>
        <fpage>e1004722</fpage>
        <pub-id pub-id-type="pmid">25357204</pub-id>
      </element-citation>
    </ref>
    <ref id="bib28">
      <label>28</label>
      <element-citation publication-type="journal" id="sref28">
        <person-group person-group-type="author">
          <name>
            <surname>Kichaev</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Roytman</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Eskin</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Lindström</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Kraft</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Pasaniuc</surname>
            <given-names>B.</given-names>
          </name>
        </person-group>
        <article-title>Improved methods for multi-trait fine mapping of pleiotropic risk loci</article-title>
        <source>Bioinformatics</source>
        <volume>33</volume>
        <year>2017</year>
        <fpage>248</fpage>
        <lpage>255</lpage>
        <pub-id pub-id-type="pmid">27663501</pub-id>
      </element-citation>
    </ref>
    <ref id="bib29">
      <label>29</label>
      <element-citation publication-type="journal" id="sref29">
        <person-group person-group-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>P.</given-names>
          </name>
        </person-group>
        <article-title>FunSPU: a versatile and adaptive multiple functional annotation-based association test of whole-genome sequencing data</article-title>
        <source>PLoS Genet.</source>
        <volume>15</volume>
        <year>2019</year>
        <fpage>e1008081</fpage>
        <pub-id pub-id-type="pmid">31034468</pub-id>
      </element-citation>
    </ref>
    <ref id="bib30">
      <label>30</label>
      <element-citation publication-type="journal" id="sref30">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Gaynor</surname>
            <given-names>S.M.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Dey</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Arnett</surname>
            <given-names>D.K.</given-names>
          </name>
          <name>
            <surname>Aslibekyan</surname>
            <given-names>S.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole-genome sequencing studies at scale</article-title>
        <source>Nat. Genet.</source>
        <volume>52</volume>
        <year>2020</year>
        <fpage>969</fpage>
        <lpage>983</lpage>
        <pub-id pub-id-type="pmid">32839606</pub-id>
      </element-citation>
    </ref>
    <ref id="bib31">
      <label>31</label>
      <element-citation publication-type="journal" id="sref31">
        <person-group person-group-type="author">
          <name>
            <surname>Guan</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Stephens</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Bayesian variable selection regression for genome-wide association studies and other large-scale problems</article-title>
        <source>Ann. Appl. Stat.</source>
        <volume>5</volume>
        <year>2011</year>
        <fpage>1780</fpage>
        <lpage>1815</lpage>
      </element-citation>
    </ref>
    <ref id="bib32">
      <label>32</label>
      <element-citation publication-type="journal" id="sref32">
        <person-group person-group-type="author">
          <name>
            <surname>De Jager</surname>
            <given-names>P.L.</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>McCabe</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Vardarajan</surname>
            <given-names>B.N.</given-names>
          </name>
          <name>
            <surname>Felsky</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>H.U.</given-names>
          </name>
          <name>
            <surname>White</surname>
            <given-names>C.C.</given-names>
          </name>
          <name>
            <surname>Peters</surname>
            <given-names>M.A.</given-names>
          </name>
          <name>
            <surname>Lodgson</surname>
            <given-names>B.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research</article-title>
        <source>Sci. Data</source>
        <volume>5</volume>
        <year>2018</year>
        <fpage>180142</fpage>
        <pub-id pub-id-type="pmid">30084846</pub-id>
      </element-citation>
    </ref>
    <ref id="bib33">
      <label>33</label>
      <element-citation publication-type="journal" id="sref33">
        <person-group person-group-type="author">
          <name>
            <surname>Bennett</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Buchman</surname>
            <given-names>A.S.</given-names>
          </name>
          <name>
            <surname>Boyle</surname>
            <given-names>P.A.</given-names>
          </name>
          <name>
            <surname>Barnes</surname>
            <given-names>L.L.</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>R.S.</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>J.A.</given-names>
          </name>
        </person-group>
        <article-title>Religious orders study and rush memory and aging project</article-title>
        <source>J. Alzheimers Dis.</source>
        <volume>64</volume>
        <year>2018</year>
        <fpage>S161</fpage>
        <lpage>S189</lpage>
        <pub-id pub-id-type="pmid">29865057</pub-id>
      </element-citation>
    </ref>
    <ref id="bib34">
      <label>34</label>
      <element-citation publication-type="journal" id="sref34">
        <person-group person-group-type="author">
          <name>
            <surname>Hormozdiari</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Gazal</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>van de Geijn</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Finucane</surname>
            <given-names>H.K.</given-names>
          </name>
          <name>
            <surname>Ju</surname>
            <given-names>C.J.T.</given-names>
          </name>
          <name>
            <surname>Loh</surname>
            <given-names>P.R.</given-names>
          </name>
          <name>
            <surname>Schoech</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Reshef</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>O'Connor</surname>
            <given-names>L.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits</article-title>
        <source>Nat. Genet.</source>
        <volume>50</volume>
        <year>2018</year>
        <fpage>1041</fpage>
        <lpage>1047</lpage>
        <pub-id pub-id-type="pmid">29942083</pub-id>
      </element-citation>
    </ref>
    <ref id="bib35">
      <label>35</label>
      <element-citation publication-type="journal" id="sref35">
        <person-group person-group-type="author">
          <name>
            <surname>Bryois</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Calini</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Macnair</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Foo</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Urich</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Ortmann</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Iglesias</surname>
            <given-names>V.A.</given-names>
          </name>
          <name>
            <surname>Selvaraj</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Nutma</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Marzin</surname>
            <given-names>M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cell-type specific cis-eQTLs in eight brain cell-types identifies novel risk genes for human brain disorders</article-title>
        <comment>Preprint at</comment>
        <source>medRxiv</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1101/2021.10.09.21264604</pub-id>
      </element-citation>
    </ref>
    <ref id="bib36">
      <label>36</label>
      <element-citation publication-type="journal" id="sref36">
        <person-group person-group-type="author">
          <name>
            <surname>Lopes</surname>
            <given-names>K.d.P.</given-names>
          </name>
          <name>
            <surname>Snijders</surname>
            <given-names>G.J.L.</given-names>
          </name>
          <name>
            <surname>Humphrey</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Allan</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Sneeboer</surname>
            <given-names>M.A.M.</given-names>
          </name>
          <name>
            <surname>Navarro</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Schilder</surname>
            <given-names>B.M.</given-names>
          </name>
          <name>
            <surname>Vialle</surname>
            <given-names>R.A.</given-names>
          </name>
          <name>
            <surname>Parks</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Missall</surname>
            <given-names>R.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies</article-title>
        <source>Nat. Genet.</source>
        <volume>54</volume>
        <year>2022</year>
        <fpage>4</fpage>
        <lpage>17</lpage>
        <pub-id pub-id-type="pmid">34992268</pub-id>
      </element-citation>
    </ref>
    <ref id="bib37">
      <label>37</label>
      <element-citation publication-type="journal" id="sref37">
        <person-group person-group-type="author">
          <name>
            <surname>Luningham</surname>
            <given-names>J.M.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>De Jager</surname>
            <given-names>P.L.</given-names>
          </name>
          <name>
            <surname>Bennett</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Buchman</surname>
            <given-names>A.S.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Bayesian genome-wide TWAS method to leverage both cis- and trans-eQTL information through summary statistics</article-title>
        <source>Am. J. Hum. Genet.</source>
        <volume>107</volume>
        <year>2020</year>
        <fpage>714</fpage>
        <lpage>726</lpage>
        <pub-id pub-id-type="pmid">32961112</pub-id>
      </element-citation>
    </ref>
    <ref id="bib38">
      <label>38</label>
      <element-citation publication-type="journal" id="sref38">
        <person-group person-group-type="author">
          <name>
            <surname>BROYDEN</surname>
            <given-names>C.G.</given-names>
          </name>
        </person-group>
        <article-title>The convergence of a class of double-rank minimization algorithms 1. General considerations</article-title>
        <source>IMA J. Appl. Math.</source>
        <volume>6</volume>
        <year>1970</year>
        <fpage>76</fpage>
        <lpage>90</lpage>
      </element-citation>
    </ref>
    <ref id="bib39">
      <label>39</label>
      <element-citation publication-type="journal" id="sref39">
        <person-group person-group-type="author">
          <name>
            <surname>Quinlan</surname>
            <given-names>A.R.</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>I.M.</given-names>
          </name>
        </person-group>
        <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>
        <source>Bioinformatics</source>
        <volume>26</volume>
        <year>2010</year>
        <fpage>841</fpage>
        <lpage>842</lpage>
        <pub-id pub-id-type="pmid">20110278</pub-id>
      </element-citation>
    </ref>
    <ref id="bib40">
      <label>40</label>
      <element-citation publication-type="journal" id="sref40">
        <person-group person-group-type="author">
          <name>
            <surname>Bennett</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Arvanitakis</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>R.S.</given-names>
          </name>
        </person-group>
        <article-title>Overview and findings from the religious orders study</article-title>
        <source>Curr. Alzheimer Res.</source>
        <volume>9</volume>
        <year>2012</year>
        <fpage>628</fpage>
        <lpage>645</lpage>
        <pub-id pub-id-type="pmid">22471860</pub-id>
      </element-citation>
    </ref>
    <ref id="bib41">
      <label>41</label>
      <element-citation publication-type="journal" id="sref41">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Beckmann</surname>
            <given-names>N.D.</given-names>
          </name>
          <name>
            <surname>Roussos</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Q.</given-names>
          </name>
          <name>
            <surname>Ming</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Neff</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Fullard</surname>
            <given-names>J.F.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease</article-title>
        <source>Sci. Data</source>
        <volume>5</volume>
        <year>2018</year>
        <fpage>180185</fpage>
        <pub-id pub-id-type="pmid">30204156</pub-id>
      </element-citation>
    </ref>
    <ref id="bib42">
      <label>42</label>
      <element-citation publication-type="journal" id="sref42">
        <person-group person-group-type="author">
          <name>
            <surname>Trevethan</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice</article-title>
        <source>Front. Public Health</source>
        <volume>5</volume>
        <year>2017</year>
        <fpage>307</fpage>
        <pub-id pub-id-type="pmid">29209603</pub-id>
      </element-citation>
    </ref>
    <ref id="bib43">
      <label>43</label>
      <element-citation publication-type="journal" id="sref43">
        <person-group person-group-type="author">
          <name>
            <surname>Bennett</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Buchman</surname>
            <given-names>A.S.</given-names>
          </name>
          <name>
            <surname>Barnes</surname>
            <given-names>L.L.</given-names>
          </name>
          <name>
            <surname>Boyle</surname>
            <given-names>P.A.</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>R.S.</given-names>
          </name>
        </person-group>
        <article-title>Overview and findings from the rush memory and aging project</article-title>
        <source>Curr. Alzheimer Res.</source>
        <volume>9</volume>
        <year>2012</year>
        <fpage>646</fpage>
        <lpage>663</lpage>
        <pub-id pub-id-type="pmid">22471867</pub-id>
      </element-citation>
    </ref>
    <ref id="bib44">
      <label>44</label>
      <element-citation publication-type="journal" id="sref44">
        <person-group person-group-type="author">
          <name>
            <surname>Bennett</surname>
            <given-names>D.A.</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>R.S.</given-names>
          </name>
          <name>
            <surname>Boyle</surname>
            <given-names>P.A.</given-names>
          </name>
          <name>
            <surname>Buchman</surname>
            <given-names>A.S.</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>J.A.</given-names>
          </name>
        </person-group>
        <article-title>Relation of neuropathology to cognition in persons without cognitive impairment</article-title>
        <source>Ann. Neurol.</source>
        <volume>72</volume>
        <year>2012</year>
        <fpage>599</fpage>
        <lpage>609</lpage>
        <pub-id pub-id-type="pmid">23109154</pub-id>
      </element-citation>
    </ref>
    <ref id="bib45">
      <label>45</label>
      <element-citation publication-type="journal" id="sref45">
        <person-group person-group-type="author">
          <name>
            <surname>Lambert</surname>
            <given-names>J.-C.</given-names>
          </name>
          <name>
            <surname>Ibrahim-Verbaas</surname>
            <given-names>C.A.</given-names>
          </name>
          <name>
            <surname>Harold</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Naj</surname>
            <given-names>A.C.</given-names>
          </name>
          <name>
            <surname>Sims</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Bellenguez</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>DeStafano</surname>
            <given-names>A.L.</given-names>
          </name>
          <name>
            <surname>Bis</surname>
            <given-names>J.C.</given-names>
          </name>
          <name>
            <surname>Beecham</surname>
            <given-names>G.W.</given-names>
          </name>
          <name>
            <surname>Grenier-Boley</surname>
            <given-names>B.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Meta-analysis of 74, 046 individuals identifies 11 new susceptibility loci for Alzheimer's disease</article-title>
        <source>Nat. Genet.</source>
        <volume>45</volume>
        <year>2013</year>
        <fpage>1452</fpage>
        <lpage>1458</lpage>
        <pub-id pub-id-type="pmid">24162737</pub-id>
      </element-citation>
    </ref>
    <ref id="bib46">
      <label>46</label>
      <element-citation publication-type="journal" id="sref46">
        <person-group person-group-type="author">
          <name>
            <surname>Carrasquillo</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Pankratz</surname>
            <given-names>V.S.</given-names>
          </name>
          <name>
            <surname>Wilcox</surname>
            <given-names>S.L.</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Walker</surname>
            <given-names>L.P.</given-names>
          </name>
          <name>
            <surname>Younkin</surname>
            <given-names>S.G.</given-names>
          </name>
          <name>
            <surname>Younkin</surname>
            <given-names>C.S.</given-names>
          </name>
          <name>
            <surname>Younkin</surname>
            <given-names>L.H.</given-names>
          </name>
          <name>
            <surname>Bisceglio</surname>
            <given-names>G.D.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease</article-title>
        <source>Nat. Genet.</source>
        <volume>41</volume>
        <year>2009</year>
        <fpage>192</fpage>
        <lpage>198</lpage>
        <pub-id pub-id-type="pmid">19136949</pub-id>
      </element-citation>
    </ref>
    <ref id="bib47">
      <label>47</label>
      <element-citation publication-type="journal" id="sref47">
        <person-group person-group-type="author">
          <name>
            <surname>Allen</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Carrasquillo</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Funk</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Heavner</surname>
            <given-names>B.D.</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Younkin</surname>
            <given-names>C.S.</given-names>
          </name>
          <name>
            <surname>Burgess</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Chai</surname>
            <given-names>H.S.</given-names>
          </name>
          <name>
            <surname>Crook</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Eddy</surname>
            <given-names>J.A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseases</article-title>
        <source>Sci. Data</source>
        <volume>3</volume>
        <year>2016</year>
        <fpage>160089</fpage>
        <pub-id pub-id-type="pmid">27727239</pub-id>
      </element-citation>
    </ref>
    <ref id="bib48">
      <label>48</label>
      <element-citation publication-type="journal" id="sref48">
        <person-group person-group-type="author">
          <collab>1000 Genomes Project Consortium</collab>
          <name>
            <surname>Auton</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Brooks</surname>
            <given-names>L.D.</given-names>
          </name>
          <name>
            <surname>DePristo</surname>
            <given-names>M.A.</given-names>
          </name>
          <name>
            <surname>Durbin</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Handsaker</surname>
            <given-names>R.E.</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>H.M.</given-names>
          </name>
          <name>
            <surname>Marth</surname>
            <given-names>G.T.</given-names>
          </name>
          <name>
            <surname>McVean</surname>
            <given-names>G.A.</given-names>
          </name>
        </person-group>
        <article-title>An integrated map of genetic variation from 1, 092 human genomes</article-title>
        <source>Nature</source>
        <volume>491</volume>
        <year>2012</year>
        <fpage>56</fpage>
        <lpage>65</lpage>
        <pub-id pub-id-type="pmid">23128226</pub-id>
      </element-citation>
    </ref>
    <ref id="bib49">
      <label>49</label>
      <element-citation publication-type="journal" id="sref49">
        <person-group person-group-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>S.W.</given-names>
          </name>
          <name>
            <surname>Mak</surname>
            <given-names>T.S.H.</given-names>
          </name>
          <name>
            <surname>O'Reilly</surname>
            <given-names>P.F.</given-names>
          </name>
        </person-group>
        <article-title>Tutorial: a guide to performing polygenic risk score analyses</article-title>
        <source>Nat. Protoc.</source>
        <volume>15</volume>
        <year>2020</year>
        <fpage>2759</fpage>
        <lpage>2772</lpage>
        <pub-id pub-id-type="pmid">32709988</pub-id>
      </element-citation>
    </ref>
    <ref id="bib50">
      <label>50</label>
      <element-citation publication-type="journal" id="sref50">
        <person-group person-group-type="author">
          <name>
            <surname>Euesden</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>C.M.</given-names>
          </name>
          <name>
            <surname>O'Reilly</surname>
            <given-names>P.F.</given-names>
          </name>
        </person-group>
        <article-title>PRSice: polygenic risk score software</article-title>
        <source>Bioinformatics</source>
        <volume>31</volume>
        <year>2015</year>
        <fpage>1466</fpage>
        <lpage>1468</lpage>
        <pub-id pub-id-type="pmid">25550326</pub-id>
      </element-citation>
    </ref>
    <ref id="bib51">
      <label>51</label>
      <element-citation publication-type="journal" id="sref51">
        <person-group person-group-type="author">
          <name>
            <surname>Privé</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Arbel</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Vilhjálmsson</surname>
            <given-names>B.J.</given-names>
          </name>
        </person-group>
        <article-title>LDpred2: better, faster, stronger</article-title>
        <source>Bioinformatics</source>
        <volume>36</volume>
        <year>2020</year>
        <fpage>5424</fpage>
        <lpage>5431</lpage>
      </element-citation>
    </ref>
    <ref id="bib52">
      <label>52</label>
      <element-citation publication-type="journal" id="sref52">
        <person-group person-group-type="author">
          <name>
            <surname>Ge</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>C.Y.</given-names>
          </name>
          <name>
            <surname>Ni</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Y.C.A.</given-names>
          </name>
          <name>
            <surname>Smoller</surname>
            <given-names>J.W.</given-names>
          </name>
        </person-group>
        <article-title>Polygenic prediction via Bayesian regression and continuous shrinkage priors</article-title>
        <source>Nat. Commun.</source>
        <volume>10</volume>
        <year>2019</year>
        <fpage>1776</fpage>
        <pub-id pub-id-type="pmid">30992449</pub-id>
      </element-citation>
    </ref>
    <ref id="bib53">
      <label>53</label>
      <element-citation publication-type="journal" id="sref53">
        <person-group person-group-type="author">
          <name>
            <surname>Linden</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis</article-title>
        <source>J. Eval. Clin. Pract.</source>
        <volume>12</volume>
        <year>2006</year>
        <fpage>132</fpage>
        <lpage>139</lpage>
        <pub-id pub-id-type="pmid">16579821</pub-id>
      </element-citation>
    </ref>
    <ref id="bib54">
      <label>54</label>
      <element-citation publication-type="journal" id="sref54">
        <person-group person-group-type="author">
          <name>
            <surname>Hansen</surname>
            <given-names>D.V.</given-names>
          </name>
          <name>
            <surname>Hanson</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Sheng</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Microglia in Alzheimer's disease</article-title>
        <source>J. Cell Biol.</source>
        <volume>217</volume>
        <year>2018</year>
        <fpage>459</fpage>
        <lpage>472</lpage>
        <pub-id pub-id-type="pmid">29196460</pub-id>
      </element-citation>
    </ref>
    <ref id="bib55">
      <label>55</label>
      <element-citation publication-type="journal" id="sref55">
        <person-group person-group-type="author">
          <name>
            <surname>Mathys</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Davila-Velderrain</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Mohammadi</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>J.Z.</given-names>
          </name>
          <name>
            <surname>Menon</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Abdurrob</surname>
            <given-names>F.</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>X.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Single-cell transcriptomic analysis of Alzheimer's disease</article-title>
        <source>Nature</source>
        <volume>570</volume>
        <year>2019</year>
        <fpage>332</fpage>
        <lpage>337</lpage>
        <pub-id pub-id-type="pmid">31042697</pub-id>
      </element-citation>
    </ref>
    <ref id="bib56">
      <label>56</label>
      <element-citation publication-type="journal" id="sref56">
        <person-group person-group-type="author">
          <name>
            <surname>Kunkle</surname>
            <given-names>B.W.</given-names>
          </name>
          <name>
            <surname>Grenier-Boley</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Sims</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Bis</surname>
            <given-names>J.C.</given-names>
          </name>
          <name>
            <surname>Damotte</surname>
            <given-names>V.</given-names>
          </name>
          <name>
            <surname>Naj</surname>
            <given-names>A.C.</given-names>
          </name>
          <name>
            <surname>Boland</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Vronskaya</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>van der Lee</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Amlie-Wolf</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing</article-title>
        <source>Nat. Genet.</source>
        <volume>51</volume>
        <year>2019</year>
        <fpage>414</fpage>
        <lpage>430</lpage>
        <pub-id pub-id-type="pmid">30820047</pub-id>
      </element-citation>
    </ref>
    <ref id="bib57">
      <label>57</label>
      <element-citation publication-type="journal" id="sref57">
        <person-group person-group-type="author">
          <name>
            <surname>Takei</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Miyashita</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Tsukie</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Arai</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Asada</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Imagawa</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Shoji</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Higuchi</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Urakami</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Kimura</surname>
            <given-names>H.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese</article-title>
        <source>Genomics</source>
        <volume>93</volume>
        <year>2009</year>
        <fpage>441</fpage>
        <lpage>448</lpage>
        <pub-id pub-id-type="pmid">19442637</pub-id>
      </element-citation>
    </ref>
    <ref id="bib58">
      <label>58</label>
      <element-citation publication-type="journal" id="sref58">
        <person-group person-group-type="author">
          <name>
            <surname>Wojcik</surname>
            <given-names>G.L.</given-names>
          </name>
          <name>
            <surname>Graff</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Nishimura</surname>
            <given-names>K.K.</given-names>
          </name>
          <name>
            <surname>Tao</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Haessler</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Gignoux</surname>
            <given-names>C.R.</given-names>
          </name>
          <name>
            <surname>Highland</surname>
            <given-names>H.M.</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>Y.M.</given-names>
          </name>
          <name>
            <surname>Sorokin</surname>
            <given-names>E.P.</given-names>
          </name>
          <name>
            <surname>Avery</surname>
            <given-names>C.L.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genetic analyses of diverse populations improves discovery for complex traits</article-title>
        <source>Nature</source>
        <volume>570</volume>
        <year>2019</year>
        <fpage>514</fpage>
        <lpage>518</lpage>
        <pub-id pub-id-type="pmid">31217584</pub-id>
      </element-citation>
    </ref>
    <ref id="bib59">
      <label>59</label>
      <element-citation publication-type="journal" id="sref59">
        <person-group person-group-type="author">
          <name>
            <surname>Andaleon</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Mogil</surname>
            <given-names>L.S.</given-names>
          </name>
          <name>
            <surname>Wheeler</surname>
            <given-names>H.E.</given-names>
          </name>
        </person-group>
        <article-title>Gene-based association study for lipid traits in diverse cohorts implicates BACE1 and SIDT2 regulation in triglyceride levels</article-title>
        <source>PeerJ</source>
        <volume>6</volume>
        <year>2018</year>
        <fpage>e4314</fpage>
        <pub-id pub-id-type="pmid">29404214</pub-id>
      </element-citation>
    </ref>
    <ref id="bib60">
      <label>60</label>
      <element-citation publication-type="journal" id="sref60">
        <person-group person-group-type="author">
          <name>
            <surname>Naj</surname>
            <given-names>A.C.</given-names>
          </name>
          <name>
            <surname>Jun</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Beecham</surname>
            <given-names>G.W.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L.-S.</given-names>
          </name>
          <name>
            <surname>Vardarajan</surname>
            <given-names>B.N.</given-names>
          </name>
          <name>
            <surname>Buros</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Gallins</surname>
            <given-names>P.J.</given-names>
          </name>
          <name>
            <surname>Buxbaum</surname>
            <given-names>J.D.</given-names>
          </name>
          <name>
            <surname>Jarvik</surname>
            <given-names>G.P.</given-names>
          </name>
          <name>
            <surname>Crane</surname>
            <given-names>P.K.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease</article-title>
        <source>Nat. Genet.</source>
        <volume>43</volume>
        <year>2011</year>
        <fpage>436</fpage>
        <lpage>441</lpage>
        <pub-id pub-id-type="pmid">21460841</pub-id>
      </element-citation>
    </ref>
    <ref id="bib61">
      <label>61</label>
      <element-citation publication-type="journal" id="sref61">
        <person-group person-group-type="author">
          <name>
            <surname>Karch</surname>
            <given-names>C.M.</given-names>
          </name>
          <name>
            <surname>Jeng</surname>
            <given-names>A.T.</given-names>
          </name>
          <name>
            <surname>Nowotny</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Cady</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Cruchaga</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Goate</surname>
            <given-names>A.M.</given-names>
          </name>
        </person-group>
        <article-title>Expression of novel Alzheimer’s disease risk genes in control and Alzheimer’s disease brains</article-title>
        <source>PLoS One</source>
        <volume>7</volume>
        <year>2012</year>
        <fpage>e50976</fpage>
        <pub-id pub-id-type="pmid">23226438</pub-id>
      </element-citation>
    </ref>
    <ref id="bib62">
      <label>62</label>
      <element-citation publication-type="journal" id="sref62">
        <person-group person-group-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>R.C.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>F.R.</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>M.S.</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>H.F.</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>Association of HLA-DRB1 polymorphism with Alzheimer's disease: a replication and meta-analysis</article-title>
        <source>Oncotarget</source>
        <volume>8</volume>
        <year>2017</year>
        <fpage>93219</fpage>
        <lpage>93226</lpage>
        <pub-id pub-id-type="pmid">29190991</pub-id>
      </element-citation>
    </ref>
    <ref id="bib63">
      <label>63</label>
      <element-citation publication-type="journal" id="sref63">
        <person-group person-group-type="author">
          <name>
            <surname>Novikova</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Kapoor</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Tcw</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Abud</surname>
            <given-names>E.M.</given-names>
          </name>
          <name>
            <surname>Efthymiou</surname>
            <given-names>A.G.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>S.X.</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Fullard</surname>
            <given-names>J.F.</given-names>
          </name>
          <name>
            <surname>Bendl</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integration of Alzheimer’s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes</article-title>
        <source>Nat. Commun.</source>
        <volume>12</volume>
        <year>2021</year>
        <fpage>1610</fpage>
        <pub-id pub-id-type="pmid">33712570</pub-id>
      </element-citation>
    </ref>
    <ref id="bib64">
      <label>64</label>
      <element-citation publication-type="journal" id="sref64">
        <person-group person-group-type="author">
          <name>
            <surname>Nelson</surname>
            <given-names>R.M.</given-names>
          </name>
          <name>
            <surname>Pettersson</surname>
            <given-names>M.E.</given-names>
          </name>
          <name>
            <surname>Carlborg</surname>
            <given-names>Ö.</given-names>
          </name>
        </person-group>
        <article-title>A century after Fisher: time for a new paradigm in quantitative genetics</article-title>
        <source>Trends Genet.</source>
        <volume>29</volume>
        <year>2013</year>
        <fpage>669</fpage>
        <lpage>676</lpage>
        <pub-id pub-id-type="pmid">24161664</pub-id>
      </element-citation>
    </ref>
    <ref id="bib65">
      <label>65</label>
      <element-citation publication-type="journal" id="sref65">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Carbonetto</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Stephens</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Polygenic modeling with bayesian sparse linear mixed models</article-title>
        <source>PLoS Genet.</source>
        <volume>9</volume>
        <year>2013</year>
        <fpage>e1003264</fpage>
        <pub-id pub-id-type="pmid">23408905</pub-id>
      </element-citation>
    </ref>
  </ref-list>
  <sec id="appsec1">
    <title>Web resources</title>
    <p id="p0200">BFGWAS_QUANT Github directory, <ext-link ext-link-type="uri" xlink:href="https://github.com/yanglab-emory/BFGWAS_QUANT" id="intref0050">https://github.com/yanglab-emory/BFGWAS_QUANT</ext-link></p>
    <p id="p0205">LDpred, <ext-link ext-link-type="uri" xlink:href="https://github.com/bvilhjal/ldpred" id="intref0055">https://github.com/bvilhjal/ldpred</ext-link></p>
    <p id="p0210">MCADGC data, <ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn2910256" id="intref0060">https://www.synapse.org/#!Synapse:syn2910256</ext-link></p>
    <p id="p0215">PRS-CS, <ext-link ext-link-type="uri" xlink:href="https://github.com/getian107/PRScs" id="intref0065">https://github.com/getian107/PRScs</ext-link></p>
    <p id="p0220">RADC Research Resource Sharing Hub, <ext-link ext-link-type="uri" xlink:href="http://www.radc.rush.edu/" id="intref0070">http://www.radc.rush.edu/</ext-link></p>
    <p id="p0225">Roadmap, <ext-link ext-link-type="uri" xlink:href="http://www.roadmapepigenomics.org/" id="intref0075">http://www.roadmapepigenomics.org/</ext-link></p>
    <p id="p0230">ROS/MAP data, <ext-link ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn3219045" id="intref0080">https://www.synapse.org/#!Synapse:syn3219045</ext-link></p>
  </sec>
  <sec id="appsec3" sec-type="supplementary-material">
    <title>Supplemental information</title>
    <p id="p0250">
      <supplementary-material content-type="local-data" id="mmc1">
        <caption>
          <title>Document S1. Figures S1–S9 and Supplemental methods</title>
        </caption>
        <media xlink:href="mmc1.pdf"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="mmc2">
        <caption>
          <title>Document S2. Article plus supplemental information</title>
        </caption>
        <media xlink:href="mmc2.pdf"/>
      </supplementary-material>
    </p>
  </sec>
  <ack id="ack0010">
    <title>Acknowledgments</title>
    <p id="p0235">J.Y. is supported by <funding-source id="gs1"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000002</institution-id><institution>NIH</institution></institution-wrap></funding-source>/NIGMS grant R35GM138313 and NIH/<funding-source id="gs3"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000049</institution-id><institution>NIA</institution></institution-wrap></funding-source> grant R21AG070659. ROS/MAP study data were provided by the <funding-source id="gs4">Rush Alzheimer’s Disease Center</funding-source>, <funding-source id="gs5">Rush University Medical Center</funding-source>, Chicago, IL. Data collection was supported through funding by NIA grants P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, U01AG46152, and U01AG61356; the <funding-source id="gs6"><institution-wrap><institution-id institution-id-type="doi">10.13039/100004888</institution-id><institution>Illinois Department of Public Health</institution></institution-wrap></funding-source>; and the <funding-source id="gs7"><institution-wrap><institution-id institution-id-type="doi">10.13039/100017803</institution-id><institution>Translational Genomics Research Institute</institution></institution-wrap></funding-source>. The MCADGC, led by Dr. Nilüfer Ertekin-Taner and Dr. Steven G. Younkin, Mayo Clinic, Jacksonville, FL, uses samples from the Mayo Clinic Study of Aging, the Mayo Clinic Alzheimer’s Disease Research Center, and the Mayo Clinic Brain Bank. MCADGC data collection was supported through funding by NIA grants P50 AG016574, R01 AG032990, U01 AG046139, R01 AG018023, U01 AG006576, U01 AG006786, R01 AG025711, R01 AG017216, and R01 AG003949; <funding-source id="gs8"><institution-wrap><institution-id institution-id-type="doi">10.13039/100000065</institution-id><institution>NINDS</institution></institution-wrap></funding-source> grant R01 NS080820; the <funding-source id="gs9">CurePSP Foundation</funding-source>, and support from the <funding-source id="gs10"><institution-wrap><institution-id institution-id-type="doi">10.13039/100007048</institution-id><institution>Mayo Foundation</institution></institution-wrap></funding-source>.</p>
    <sec sec-type="COI-statement" id="sec7">
      <title>Declaration of interests</title>
      <p id="p0240">D.A.B. receives a consulting fee from B4X Inc. for advising on neurodegenerative disease.</p>
    </sec>
  </ack>
  <fn-group>
    <fn id="appsec2" fn-type="supplementary-material">
      <p id="p0245">Supplemental information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.xhgg.2022.100143" id="intref0085">https://doi.org/10.1016/j.xhgg.2022.100143</ext-link>.</p>
    </fn>
  </fn-group>
</back>
